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ABSTRACT
Proteins are responsible for various functions throughout organisms, or within the
systems, they operate. Active-sites or functional/ binding sites are regions responsible for
activity in a protein; they serve as a catalyst for reactions, attach or bind to other
molecules (ligands), and maintain function. With the profusion of protein sequence and
structure data, it's increasingly relevant to develop automated methods of identifying and
investigating active-sites for proteins. Active-sites identification will have a direct
impact: in better understanding molecular basis for diseases, assisting in drug design, the
study of targeting mutants, and for functional annotation of unknown proteins. The
proper knowledge of active-sites will also be beneficial in protein design and
engineering. Existing computational approaches to active-site identification fall short of
the ideal. Several approaches fail to include some critical information, such as, global
structure, local structure, amino acid position, and local biochemical properties. Here we
present msTALI (Multiple Structure Torsion Angle Alignment) to better understand and
characterize protein sequence-structure-function relationships.
The existing studies establishing our understanding of active-sites stress the importance
of sequence, structure, and biochemical properties of proteins in their function.
Therefore, an ideal method for active-site analysis should consider all the information
above. The msTALI tool is unique compared to other existing software in that it
incorporates sequence, structure and biochemical properties of amino acids to perform its
analysis. Furthermore, msTALI generates competitive results and exhibits an ability to
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address proteins undergoing rigid-body motion. Additionally, the customization
capability of msTALI makes it an expandable algorithm; suitable for the valid
identification of active-sites.
We utilize msTALI successful structural alignment capabilities under premises
for active-site studies. The theoretical background is paramount since the research is
interdisciplinary. We discuss molecular biological constructs, relate such descriptions to
active-site research, survey previous methods, and expand our methodology. The
msTALI software is used first to examine sets of proteins with confirmed ATPase
activity. We use several fold families to evaluate effectiveness. Additionally, we map the
trajectory for additional studies with upward of ten functional classes of proteins to
strengthen the targeting set of proteins for observation. Collectively, findings will expand
the understanding of active-sites, yield development for automated site description, and
generate the programmatic development of software.
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CHAPTER 1
INTRODUCTION: INTRODUCTORY BIOLOGY
Herein, research is interdisciplinary work that includes topics from Biological and
Computational Sciences. We focus on proteins with the aim to understand function. The
objective is to establish a body of work efficiently comparable to current functional
studies, given the breadth of biological data available. Additionally, we discuss how our
methodology will suitably address protein function and contribute to the field.
Within a bubble or rather, under a controlled environment, the intricacies of
protein interaction can be captured and observed. Still, there is more to research. Though
simple to grasp, the concept of these biomolecular constructs working as portions of a
whole is also demonstrative of complex relationships and numerous interactions; this
truly sets the tone for a plethora of valuable protein studies. Notably, as topics in
bioinformatics/ computational biology would suggest; we use computers to aid in
genomic studies whether they are a sequence, structure, and or functionally based
construct. Addressing what transpires/ the true "how to" concerning proteins themselves
and with specialization, at that, is difficult. What is it that distinguishes the required input
forming organs such as the heart or intestine? How do we characterize the function of
proteins based on all contributing factors using a consistent methodology? Exploration of
protein function is salient, and the interactions of bindings amongst each protein serve as
a point for foundational reference. Active-sites identification will have a direct impact: in
better understanding molecular basis for diseases, assisting in drug design, the study of
1

targeting mutants, and for functional annotation of unknown proteins. The proper
knowledge of active-sites will also be beneficial in protein design and engineering.
Definitively, active-sites are regions where bindings occur and describe protein function.
We discuss approaches for active-sites identification. We first describe protein makeup
for component features and functionality. Then we explicitly specify the functionality and
expansions on active-sites identification for our research. The contribution and
methodology is novel and will utilize the preexisting in-house software. Development of
a revamped interface coupled with a submitted application to active-sites identification is
the target. We outline studies used for testing our existing software to build the
framework for development.
1.1 PROTEINS
Proteins constitute an important class of biomolecules that are analogous to
workers in a factory. Proteins account for both the makeup and execution of functions
carried out by cells. Describing the hierarchy, bundles of cells uniquely form tissue, and
tissues formulate organs. At the highest level, we understand that organs are the selfcontained components for living beings and further each serves vital roles in life
processes; one's heart or brain does not perform the tasks of the liver or intestine. It is
increasingly evident that proteins are an agent of how our bodies work. Ergo, it is equally
vital/ there is much value in understanding what proteins are.
As termed, proteins are called polypeptides because peptide bonds conjoin several
amino acids. Describing proteins in this manner yields information relating to proteins
sequence. The sequence outlines the amino acid chains that formulate the protein.
Generally, several amino acids make up a single protein and attribute to a proteins length.
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Lengths can vary, and account for diversity amongst any set of proteins. For example,
here, we study proteins ranging from hundreds to thousands in length, with average sizes
being roughly 300 amino acid residues. Generally, these lengths are described as
residues because we are referring to molecules bonded to each amino acid in the protein
sequence [1].
Interestingly enough, though proteins vary in length the combinations of
sequences are comprised of 20 primary amino acids. Each amino acid has an acronym
used for labeling the sequence description which can be described as follows: Alanine
(A), Cysteine (C), Aspartic acid (D), Glutamic acid (E), Phenylalanine (F), Glycine (G),
Histidine (H), Isoleucine (I), Lysine (K), Leucine (L), Methionine (M), Asparagine (N),
Proline (P), Glutamine (Q), Arginine (R), Serine (S), Threonine (T), Valine (V),
Tryptophan (W), and Tyrosine (Y) [1].
Nonetheless, the arrangement of these 20 amino acids varies and when discussed
concerning their chemical properties, account for more detailed descriptions of the
proteins we study. In fact, not only do these 20 amino acids and protein properties
account for diversity amongst proteins themselves; each also performs functions based on
the organism or system they are inherently used. The function relates to bindings, and, as
such, we elaborate on active-sites; they are the area of focus for these studies.
1.2 ACTIVE SITES
Active-sites are areas where reactions and binding events take place and therefore,
they describe a protein's function. They are synonymous with binding sites and or
binding regions, as they apply to enzymatic and cofactor relationships that are indeed,
actually reacting in some way. Hitting home, these locations on proteins are active and
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responsible for conjoining relationships like that of a puzzle; pieced or bound together.
Further, the functional regions catalyze change within the system. Active-sites typically
are described as regions on proteins demonstrative of some prominent features. For
example, active-sites exist in clefts or pocket regions of proteins. Considering the
globular nature of a protein surface, this makes sense. Mentioning the surface of proteins
is essential too. Active-sites though sometimes found in the back of cleft regions, also
have attributes or valuable structural components which make them surface accessible or
partially exposed during the dynamics undergone with protein function; these changes
can be chemical too. Identifying active-sites relies on biologically confirmed information,
especially to date. We recognize conserved regions as the areas of a protein that is
structurally similar or important to structural alignments obtained from our approach.
Conserved regions are then used for active-site identification by referring to biologically
confirmed annotations. The coupling of the two promotes the foundation of information
causal to application development; our methodology first developed for structural
alignment is implement with a new interface and applications specific to active-sites.
Next we describe the purely structural elements of proteins.
1.3 PROTEIN STRUCTURAL ELEMENTS
Proteins are characterized chiefly by having primary, secondary, and tertiary
structure. Primary structure refers to a proteins sequence-based information. The
characteristics depicted by its amino acid chain, as mentioned in the previous section.
Secondary structure and tertiary structure refers to the shape of a protein, each of which
we can elaborate on further. Not of focus is quaternary structure as it pertains to proteins
shape in complex or folded units.
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1.3.1 Secondary Structure
With the orientation of amino acid chains comes the fold developed by bonds of
the molecules within each residue. The interactions between residues are critical to shape.
Secondary structures are descriptions of the central backbone atoms. They include Alpha
Helices (α-helices), Beta Sheets (β-sheets), and coil regions. Notably, it is the hydrogen
bonding that causes these centralized shapes. An α-helix is a structural motif categorized
by a spiraling shape as pictured in Figure 1.1. Similarly, Figure 1.2 displays a β-sheet
which is formed by two β-strands (yellow) which fold somewhat parallel to one another
like two flat layers or planks. Coil regions are essentially areas within proteins where the
structures don't fit a particular motif but may be dynamic or flexible in conformity
(Figure 1.3). Secondary structures in this regard, describe shapes within a protein, but
may not explain the global structure for a protein.
1.3.2 Tertiary Structure
Tertiary structure describes the overall three-dimensional (3D) shape of a protein.
They illustrate both the central backbone and side chain components of each amino acid
bonded within that particular protein. The folds and the shape of a protein form due to
chemical interactions. Bonding properties as mentioned before, attractive and repulsive
forces, and even hydrophobic interactions play a role. Further, regardless if it is the
molecular collisions allowable or its relationship with water, acceptable folding and
shapes of proteins are relevant for description, classification, and functionality. We
explore all of these structural elements and more when employing our approach and
further investigating our active-site studies.
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CHAPTER 2
ACTIVE SITE DESCRIPTION
In this work, we define active-sites as locations on proteins that are causal to
function. An active-sites size, location, and chemical components all affect the function
and need of proteins within the system they operate. Moreover, if proteins demonstrate a
similar role, then those same proteins will also have mirroring structural similarities. Our
direct premise and novel approach for active-sites description (ASD) supports this notion.
Our definition for ADS is to provide the location and central regions on a protein needed/
necessary for protein function. The problem is developing a methodology that does this
reliably. Capturing the direct relationship between the function and structure of a protein
is critical in better understanding the mechanism of its function. The sequence-structurefunction relationships for proteins need be unbroken. This task embodies intricacy since
such relationships require accurate descriptions that are not always classified or
recognizable. It turns out that several factors contribute to functionality; conformity,
location, size of active-sites, ligand binding properties, and regions of proteins that are
surface accessible, all play a role.
Further, it isn't known which of these factors affect function most. The inherent
problem is the development of an automated methodology, inclusive of all factors, that
successfully identifies binding regions and the most significant structures. To this matter,
a completing ASD through computational methods is addressed.
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Figure 1.1 An Alpha Helix. Here we see a secondary structure characteristic common to protein structure.
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Figure 1.2 A Beta Sheet. Here we see a secondary structure characteristic common to protein
structure. Note: Beta sheets are beta stands folded with relationship to each other, each yellow
portion constitutes a strand.

9
Figure 1.3 Coil Regions of proteins. Here we see a secondary structure
characteristic of proteins that are more flexible. A. illustrates a bend or
turn region (cyan) and non-secondary structure features (coil/ grey) that
are non-continuous. B. are continuous coil regions, here we also see beta
bridge structures in gold. C. A 3/10 helix structure.

2.1 PREVIOUS WORK
Computational methods of identifying active-sites on proteins have been
introduced as early as 1960. Since then more advanced computational methods
incorporating graph-theoretic or even probabilistic techniques have been presented with a
substantial contribution to the field. While these methods have demonstrated progress,
they exhibit individual shortcomings that need to be addressed. In the following sections,
three classes of the most advanced techniques are reviewed concerning approaches that
employ common strategy types, and we outline their strengths and weaknesses.
2.1.1 Method One: Geometric and Graph-based Approaches
One intricacy with ADS manifests in the shapes of proteins themselves. Surface
representations for proteins demonstrate their globular nature. There is an unevenness
witnessed on the protein surface [2], which makes it relevant to utilize docking
techniques to explore interactions. A simple description of docking strategies
characterizes enzymatic activity or how proteins engage with any of their cofactors at the
surface level, i.e., binding regions for active-sites by attempting to piece them together
like a puzzle. Our first methods use geometric principals and graph-based ideologies for
the problem. Geometric approaches are starting points mapping the proteins space, from
which, grids are used [3]. Here we mention POCKET, which is a reliable tool and
algorithm since its geometric nature is straightforward. The surface of a protein is
scanned based on Cartesian coordinates. The grid points are used to describe distances
and available reliefs and anomalies on the protein surface, to define them as clefts/
pockets. The method scans for pocket areas subject to docking without prior knowledge
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of binding site location [3]. However, the orientation of the protein needs to be constant
in the grid space.
Additional grid-based methods like LIGSITE aim to reduce Cartesian dependency
by adding other orientation perspectives [2]. Increasing orientation perspectives is precise
for pocket detection but requires more calculation. Geometric tools serve beneficial since
they are accurate and map the protein space. Though it is difficult to pinpoint the end of
pockets and free space markers, these graphing techniques dominate the field; they
require no prior knowledge and measure clefts/ pockets observable on proteins. They fall
short of ideal due to a dependency on grid orientations, and circumventing these restraints
requires more calculations typically.
2.1.2 Method Two: Ranking and Learning Techniques
It is evident that the cavity features are relevant [4]. Improvements for geometric
or graph-based tools are developed by focusing on cavities or the pockets themselves.
CAST is a computational method that identifies and measures the size of pockets using
graph-based attributes and modeling techniques. Convex hull representations provide
shape descriptions and are beneficial for both scientific significance and binding
reliability [4]. The size of a pocket will allude to what can and cannot bind to a specific
region. From this contribution, it is common to incorporate cavity/ cleft region rankings,
categories, and representations [5][6]. Specifically, research suggests that when several
clefts are detected ranking them by size is essential. Using bounds around the structures
further demonstrates that more often than not, the larger cavity is responsible for binding
[7]. Here we see an even stronger representation of a proteins surface structure
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representation. However, surfaces and some principal components for function are not
static. Surface variation is common, and these approaches do not account for dynamics.
Ranking and predicting clefts for active-sites expands to other catalytic locations
on proteins that are dynamic and facilitate functions. Graph-theoretic methods also
incorporate hashing techniques for feature recognition [8]. Since these relationships aren't
direct fuzzy functional forms (FFFs) are adapted to practice [9][10]. FFFs aid in exposing
the notion that fold families must be able to perform several functions. A FFF approach
does well for annotating proteins and finding motifs for ASD. The disadvantage comes
when trying to match motifs to novel structures [11]. Procedures then apply Neural
Networks (NN) for comparing the structure-function similarities [11]. NN training tactics
learn the likelihood protein residues are indeed catalytic. NN is reliable for working with
novel structures but are subject to improper training for proteins with multiple or unique
catalytic regions of any particular sub-family [11]. Collectively, ranking cavities and
applying learning techniques for ADS is advantageous for further classifying essential
protein structures, notating motifs, and learning emerging proteins. The disadvantages of
these methods standout when considering dynamics; they fail when working with flexible
binding sites too.
2.1.3 Method Three: Online Tools
Several web services are aiming to address ASD also [12][13][14]. We utilize
them as comparison methods to discuss our approach which works since they are all
based on the similar established frameworks/ background information. We see that
Continuous Optimization (CO) creates a pairwise comparison between two proteins to
address functional regions [8]. Further, Molecular Local Surface Comparison (MolLoc)
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does too [15]. SiteEngine is a recognized method for pairwise docking descriptions with
hash triangles [16]. SuMo incorporates chemical groups with structural representations
[13], and pdbFun is a web service that breaks its analysis at the residue level [17].
Binding Site Finder (BsFinder) methodology provides a three-step process similar to our
goal since it incorporates sequence and structure info [18]. These methods supply a visual
platform. The overarching shortcoming is each of these examples fall victim to the
limitations mentioned above. Additionally, the approaches trend to identify active-sitess
with precisions not exceeding a 65% success rate. A valuable rate considering the nature
of the problem, but there is room for improvement.
2.2 SUMMARY
There are shortcomings concerning some critical information for the more
extensive description of active-sites. It is considered worth noting that within the
drawbacks, most approaches focus on the annotation of an individual protein or utilizes
two proteins to establish binding qualities. We find it beneficial to regard groups of
proteins. Our Multiple Structure Torsion Angle Alignment (msTALI) approach addresses
many of the deficiencies concurrently while observing multiple proteins simultaneously
[19]. We generate competitive results and utilize our platform to study sets of proteins in
entirety since they too are dynamic. We consider the global and local structure, amino
acid position, and local biochemical properties. Our methodology takes advantage of the
existing engine by performing superior alignments on proteins that are documented to
achieve the same function, all while detecting dynamic confirmations; this becomes key
when addressing proteins classified with a similar role, that bind flexible ligands, and that
are non-homologous [20].
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CHAPTER 3
THE MSTALI ENGINE
The msTALI is a hybrid 1D - 3D method designed to perform structural
alignments on multiple proteins simultaneously [19]. In this project, we leverage the
existing msTALI software to develop an active-sites identification mechanism. This
chapter details explicitly the msTALI Engine, for existing functionality. The msTALI is
currently an in-house, stand-alone web-application with downloadable executables
flexible enough for expansion. So in this regard, we will mention the current core engine/
algorithm. Our Research describes programmatic development/ expansion by way of a
new interface that incorporates the existing functionality expanded and applied to
problems focusing on ASD. We describe msTALI in detail, and, we outline the work in
utilizing msTALI for ASD in proteins.
3.1 MSTALI ENGINE DESCRIPTION
The msTALI software package, developed by the ValafarLab is available for
download and use from the following URL: http://ifestos.cse.sc.edu [19]. The msTALI
approach exhibits distinct advantages over other comparable approaches as highlighted in
previous publications [19]. The TALI/ msTALI software package take advantage of both
sequence and structural information to achieve better performance. Previous work
demonstrates the success of TALI [21] and msTALI [19] as an approach which uniquely
adheres to conditions that make our task difficult. The msTALI engine is an extension of
TALI by including multiple structure alignment in a manner that is analogous to
14

ClustalW [22]. Our approach to structure alignment sets itself apart from other
methods by including structural information such as backbone torsion angles, atomic
positions, and membership of each residue in a secondary structural element, while
including alignment of sequences using the Needleman-Wunsch [23] algorithm. The
msTALI engine also includes other information such as water accessibility, structural
information of side-chains (which are essential in the biochemistry of the enzyme), and
properties of the neighboring atoms. The msTALI core engine applies these features
using a scoring metric to calculate structural alignments. We highlight the metric with
equation one, Eq. (1), it defines the function of the global dynamic programming
algorithm [19].
S(𝑟𝑖 , 𝑟𝑗 ) = 𝑤𝑡 𝑡(𝑟𝑖 , 𝑟𝑗 ) + 𝑤𝑏 𝑏(𝑟𝑖 , 𝑟𝑗 ) + 𝑤𝑟 𝑟(𝑟𝑖 , 𝑟𝑗 ) + 𝑤𝑠 𝑠(𝑟𝑖 , 𝑟𝑗 )

(1)

+𝑤𝑑𝑝 𝑑𝑝 (𝑟𝑖 , 𝑟𝑗 ) + 𝑤𝑠𝑝 𝑠𝑝 (𝑟𝑖 , 𝑟𝑗 ) + 𝑤𝑑𝑠 𝑑𝑠 (𝑟𝑖 , 𝑟𝑗 ) + 𝑤𝑠𝑠 𝑠𝑠 (𝑟𝑖 , 𝑟𝑗 )

Here, weights denoted by w subscripts, are normalized to one and applied to each scoring
feature. Features being: torsion angles (t), the backbone 𝐶 𝛼 atom position (b), residue
type (r), secondary structure type (s), and properties of nearby atoms based on distance to
and sequence types (𝑑𝑝 , 𝑑𝑠 , 𝑠𝑝 , 𝑠𝑠 ). Each evaluates and compares the score matchings for
any corresponding residues i and j. Note, however, that the score "S(𝑟𝑖 , 𝑟𝑗 )” is used by the
engine to obtain an optimal score based off of structural alignment from one residue to
the next residue.
By incorporating this framework to design, and by using a flexible platform, the
application is expandable to apply to our active-sites studies. Our work falls into two
parts, methods development, and usability and web development (maybe software). Our
next sections elaborate on the framework that will be used for the study. We aim to
15

master approaches conducive to ADS while anticipating difficulties that might occur. We
outline how to address pitfalls make our approach more reliable.
3.2 DETAIL OF WORK: OVERALL VIEW
The outlined research consists of the following three specific aims:
1.

Development of a methodology for ASD using msTALI – The primary objective

of this research is the adaptation of msTALI for use in ASD. In doing so, our lab
resources will be updated and current, improvements to the computational methodologies
for active-sites identification explored, and we will contribute to research of the common
core while expanding knowledge and mastering understanding for current practice. The
background for the study is extensive, in that, in-depth exploration of computational
approaches is necessary. Further, surveying such attitudes becomes interdisciplinary and
establishes the framework for experimental procedures.
2.

Optimizing the parameters of msTALI for ASD – We anticipate that as the

functions of proteins change, so will the intricate attributes that contribute to the changes.
For example, some proteins might have physical components that are responsible for
facilitating function; a door, gate, or hinged region that enables binding. In these cases, it
would make sense to increase the significance of parameters that weigh secondary
structural importance. With msTALI, we can adjust features independently. The msTALI
engine uses scoring features that quantify the effectiveness of structural alignments. If
needed, we are prepared to conduct studies optimizing msTALI’s operational parameters
specific in use for ASD because it could prove critical to our methodology.
3.

Development of a user interface useful for ASD studies – Working to develop a

new interface for msTALI is relatively simple to describe since this stage is ongoing.
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Several of the features are beneficial to usability for conducting studies. We discuss
changes to the web-presence to provide aesthetics advantageous to methodology.
However, catering msTALI to ADS is a robust process that will require more than
website changes since the upgrades mirror our three thrusts directly to practice.
Contributions will primarily fall into three categories in conjunction with research
studies. Classes being: the methodology for discovering active-sites with msTALI,
optimizing the preprogrammed parameters within the msTALI engine for ADS, and
usability for the user interface improvements.
3.2.1 Aim 1: Development of a Methodology for ASD Using msTALI
We will develop and evaluate a process that is advantageous in the identification
of active-sites. Our developments proceed based on the underlying hypothesis that
structure-sequence alignment of multiple proteins with common function will reveal the
conserved regions (structural and sequence), which must contain the active-sites and
motifs salient to functionality. The initial strategy that we will pursue will depend on the
alignment of multiple structures with a similar function using msTALI. However, we
anticipate the following scenarios when aligning proteins. There will be active-sites not
recognized by our conserved region alignments. These more detrimental conditions are
attributed to various factors which make ASD challenging to define.
With our first scenario, we state that some active-sites will be underrepresented
because several proteins perform more than one function. This scenario confuses our
approach based on function prominence, or perhaps by failing to separate the functions
appropriately. Provided the possibility that proteins perform more than one function, we
propose documenting all of the reported ligands and cofactors each protein binds. We
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will use the PDB [24] to collect binding information. Our initial test will align the
proteins based on a single common functionality. Then we will incorporate the
documented subcategories of functions for subsequent use based on any additional
functionality. Through reporting and subsequent use (based on multiple protein
functions), we will use the subsets of regions returned from msTALI as a collection of
information pertinent to ASD.
We also anticipate the case that conserved regions will stand out, but will
demonstrate residue shifts left or right of the documented sequence location. We attribute
residue shifting to the numbers of residues within a sequence alone being limiting for
ASD. For example, let’s say, the documented active-sites is recorded at residues five
through seven for some given protein. Then our results return residues numbered eight
through ten. Our location at this point is described primarily by numerical information
based on sequence position. Sequence formation alone is not enough. Structurally,
residues on either side of our hypothetical example, and even further away in residue may
be central to functionality when considering the spatial location on the protein. To
overcome this pitfall, we will again, train using the proteins with the same function. Then
we visualize the three-dimensional shape of each protein. Visualizing protein shape will
test and assure that left or right shifts of any documented active-sites residues are in a
respectable local considered important to ASD. We will report the shifts as an acceptable
threshold for accurate alignments for ASD directly.
The third scenario that we anticipate contributing to pitfalls in our approach
combines the notion that the actual functional regions of proteins are flexible for some
ligands, and proteins themselves have different structural domains/ classifications. In
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other words, for one protein a functional region might reveal itself easiest if the protein is
in some conformation “A” instead of “B.” We will test this in the method by using
phylogenetic information, in conjunction with protein shape descriptors to additionally
group and realign proteins as we did in the first scenario. Our shape description will come
from researching CATH [25] information for each target protein. We then proceed with
our approach by naively passing the structures for alignment based on the functional
similarity. However, we are now prepared to address instances where the simple
alignment yield inconsistent conserved core regions for ASD. We account for protein
dissimilarity where specific protein motifs may be less prominent in some conformations
and more in others. We can now assume that conserved core regions will stratify into
groups; some uniform and others, not so much. This divergence is challenging and
additionally attributed to proteins performing multiple functions, as mentioned in our first
scenario.
Consequently, our approach is intricate in practice when using our annotation. In
proposing, the incorporation of all annotations has to be performed in a manner that
monitors the apparent difference in groups, but not too much to where sensitivity is
neglected. We want to capture the most valuable information about what is conserved for
function by including each aspect of our approach. From here, we focus on what regions
are conserved from clusters of focused information.
Our ADS features will include conserved residues consistent across a total dataset
of proteins, and essential residues characteristic to binding sites. Collectively the above
displays motifs for functional classes. Additional attributes yielding from our approach
include annotation and secondary structural information, with an ability to align novel

19

proteins that one might envision mapping to a particular function. Again, we proceed
based on the hypothesis that structure-sequence alignment of multiple proteins with
common function will reveal the conserved regions (structural and sequence), which must
contain the active-sites. Our methodology is advantageous when compared to existing
computational methods since we observe several proteins at once.
Overall when establishing our approach for ASD, we first need to input our
proteins structures to the msTALI software. We utilize groups of proteins (ten to twenty
at a time) and use the collection for analysis (which can also be referred to as training) by
msTALI. In practice, we also record the length of proteins. Protein length affects how
many times a set of proteins undergoes training. The number of trained observations is
always less than an adjustable percentage of a proteins length (measured in residues). We
do this to avoid overfitting; it also limits the number of returned conserved regions for
proteins with high structural similarity. The msTALI alignment is conducted on the
complete group of proteins simultaneously. Here, we record the conserved residues
obtained by the analysis and evaluate phylogenetic results with CATH classification. This
classification is pivotal for our next round of training. We continue to train on each subset
grouping of the proteins, in this instance, grouped with similar phylogeny and CATH
classification. We record the number of conserved core residues again. We compare the
number of conserved regions obtained from simultaneous alignment to the number of
conserved regions obtained by our sub-classification training. Typically the simultaneous
groupings will have less conserved core residues. We use the number of conserved
regions from the simultaneous alignments with the number of conserved regions from the
sub-classification training as bounds; they are lower and upper limits respectively. The
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range of conserved regions is valuable for ASD. We use the range and an acceptable
threshold related to protein length for conserved regions we consider reliable for the
ASD.
Our methodology for ASD uses data obtained by the structural alignment of
several proteins displaying the same enzymatic activity. Each class of protein will be
submitted to msTALI as input separately. We use a collection of ten protein classes to
validate our method. Our protein classes include AMP, ATP, FAD, FMN, Glucose,
Heme, Hydrolase, NAD, Phosphate, and Steroid functioning proteins. Each subgroup will
start with a simultaneous run of the proteins to msTALI, categories comprised of roughly
15 proteins each. Table 3.1 lists our target proteins. Thus, we assess multiple proteins
while covering a diverse spread of classified protein groups commonly studied by the
field.
Verifying the success of the method for ASD relies on biologically confirmed
information. Upon concluding the complete approach on each set of proteins, we then
observe results for biologically confirmed annotations. VMD [26] will be utilized to
visualize the results of our approach. Additionally, the inclusion of additional proteins to
each set validates results. For example, say a protein is confirmed to have AMP binding,
we can add that new mentioned protein to our studied run to evaluate consistency.
Further, this templating type test can be performed on proteins – tentatively even
novel proteins – if they indeed do fit within a particular class of proteins with a function
in mind. With this methodology in mind, we can now discuss additional contributions to
the research outlined by our thrust. We have anticipated that our method might require
parameter changes as detailed in section 3.2.2 collectively; we also mention the interface
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changes in section 3.2.3 all to provide a well-rounded solution to our researched method
for ASD.
3.2.2 Aim 2: Optimizing the Parameters of msTALI for ASD
The existing implementation of msTALI is optimized for general alignment of
multiple structures. The investigations highlighted in Aim1 will help to establish the
utility of msTALI in the specific domain of active-sites identification. Aim 2 of our work
serves as a contingency plan in the event that optimizations of the parameters described
in Eq. (1) for application in ASD are required. As needed, we will investigate the
optimization of weights for ASD or optimization of weights for each class of enzymatic
activity
From an overall standpoint, it is possible that there will be a single set of weights
that works advantageously for all the studied targets for ASD. For example, and provided
some general use, we can adjust all weights in a manner such that, the normalized values
mirror characteristic reflective of concepts highlighting functional concerns. It is well
known that locations responsible for function within a protein are dynamic. ASD
incorporate regions of proteins within clefts, areas that may be surface accessible, and
have chemical properties; weights would be adjusted to address these complex
combinations. So, through algorithmic design, optimizing the used parameters for
msTALI scoring metric explores weighted features – surface accessibility, for example –
of protein residues, but also alignments based off of flexible or custom components and
not just the core, can improve an ASD.
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Table 3.1 Target Proteins of Study. We have listed, in tabular form, the proteins we will study by named grouped by their protein
classes (additional proteins for Hydrolase class include: 5F9R, 5K8I, 5KSO, 5LHB, and 5M0X. For Phosphate class include:
1L7Ma, 1LBYa, 1LYVa, 1QF5a, and 1TCOa. are listed here for spacing).
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Protein Names

Target Protein classes
AMP

ATP

FAD

FMN

Glucose

Heme

Hydrolase

NAD

Phosphate

Steroid

1AMUa

1A0Ia

1CQXa

1DNLa

1BDGa

1D0Ca

1GTP

1HEXa

1A6Q

1E3Rb

1C0Aa

1A49a

1E8Gb

1F5Va

1CQ1a

1D7Ca

1RYA

1IB0a

1B8Oc

1FDSa

1CT9a

1AYLa

1EVIb

1JA1a

1K1Wa

1DK0a

1SO4

1JQ5a

1BRWa

1J99a

1JP4a

1B8Aa

1H69a

1MVLa

1NF5c

1EQGa

1V2G

1MEWa

1CQJb

1LHUa

1KHTb

1DV2a

1HSKa

1P4Ca

2GBP

1EW0a

2GT2

1MI3a

1D1Qb

1QKTa

1QB8a

1DY3a

1JQIa

1P4Ma

1GCA

1ICQa

3V48

1OG3a

1DAKa

1TB7b

1E2Qa

1JR8b

1E20

1GCG

1NP4b

3X1D

1QAXa

1E9Ga

8GPB

1E8Xa

1K87a

1EJE

2B3F

1PO5a

4XCQ

1RLZa

1EJDc

12ASa

1ESQa

1POXa

1FLM

2HPH

1QHUa

4YQF

1S7Gb

1EUC

1GN8b

3GRSa

1WLK

4R2B

1QPAb

5AO3

1T2Da

1EW2a

2CPO

5C1S

1TOXa

1FBTb

1O9Ta

5C1T

2A5Fb

1GYPa

1RDQe

5CYO

2NPXa

1H6La

1TIDa

5D6L

1HO5b

5EG4

1L5Wa

1KVKa

Consequently, our preparation and attention to algorithmic design can account for
this research’s merit and serves as a channel prepared to address difficulties we might
encounter with our methodology.
To evaluate optimal performance based off of scoring parameters we will again
utilize proteins classified based on their enzymatic activity. We will use the AMP, ATP,
FAD, FMN, Glucose, Heme, Hydrolase, NAD, Phosphate, and Steroid functioning
proteins as a control group each containing 10 to 20 proteins at a time for a set. An
additional set of proteins, used for testing, will statistically characterize which parameter
weights are most favorable. To elaborate, we select a functional group of proteins and
proceed with the training methodology as described in section 3.2.1 using the base
parameters. The data obtained from these studies will return conserved core regions for
ASD as they relate to the default settings. Now from the same group of proteins, we
perform multiple alignments with msTALI, only altering the weights. After each
alteration, we evaluate the weighted parameter change’s effect on precision. We
anticipate that with multiple trials a form-fitting function will quantify an optimal weight.
Here, our aim is that the tested weights serve well for the other enzymatic grouping. To
verify the general optimized parameters requires a simple check with the remaining
groups of target proteins. If the optimized weights don’t serve well across the board, then
our approach would then need an approach beneficial for each enzymatic class.
Optimizing the msTALI weights for each class would require an annotated
description for each of the enzymatic optimal parameter weights. In doing so, we would
still cycle through AMP, ATP, FAD, FMN, Glucose, Heme, Hydrolase, NAD, Phosphate,
and Steroid functioning control groups. The same approach would be applied to the
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general use methodology, only now we would have to report the optimal constraints for
each class of enzymatic activity. The result would be a catalog of weight whereby the
inclusion of additional proteins would verify the alignment for proteins falling under each
class/ or concerning the desired functionality for ASD.
3.2.3 Aim 3: Usability Features for User Interface Development
The third aim of this research sets the foundation of a web-based interface to
enhance the usability of our developed technology by the community of its users. To
facilitate a productive interface and user experience, we anticipate the following
requirement from the community of users: A robust protein mark-up for ASD studies,
msTALI ASD submission capability, and msTALI ASD specific output.
For usability we describe our anticipated interface requirements as follows:
A.

Having a robust protein markup for ASD studies describes development that will

aid in our general understanding of the utility of msTALI for ASD. We note features that
seem beneficial to our process thus far. We have categorized our approach as pseudomanual, and with this, we highlight observations that would make our general studies for
ASD more concise with the current msTALI.
B.

Once our methodology is complete, we aim to expand our approach to our

community of users. Our second point is to incorporate msTALI ASD submission
capability. Here we anticipate two scenarios: one implementation enables a user to
submit a job or query for a protein study specific to ASD motifs that we have studied and
trained. This scenario is beneficial because a user can establish if a studied protein
exhibits some function that we have classified from our studies. Scenario two provides a
functionality whereby users can train for a particular function on their own using the
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ASD methodology we have introduced. From there, they can add to a collection of
continuing studies. Each scenario is beneficial to our community of users. In either case,
we anticipate worthwhile contribution to our objectives, especially regarding data
inclusion. We intend to headline the former, with the aim that it coincides directly with
our methods development. The latter will serve as an additional contingency objective.
C.

msTALI ASD output is essential for our overall analysis for active-sites. We want

to afford our users with enough information to suitably allow them to visualize the
highlighted regions considered most critical to function. The output will adhere to our
approach for ASD based on conserved core residues and phylogenetic annotations for the
proteins of our studied functions.
3.2.3A Protein Markup for ASD
Performing an alignment with msTALI displays output for conserved core regions
listed for each protein by row. The aim is to generate these same results with a markup of
documented protein information suitable for ASD. Figure 3.1 outlines the msTALI markup. We have noted some improvements to our alignment markup that facilitate more
natural observation for ASD studies.
The msTALI alignment shows a row representation for each protein. But with
more proteins, and proteins that are themselves large in residue length, it becomes
increasingly difficult to monitor the location of amino acids within the sequence.
Therefore, it makes sense to incorporate a margin which keeps track of what residue –
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Figure 3.1 Core Markup of msTALI Alignment. This picture displays a portion of the simultaneous
alignment for three proteins the circled stars denote conserved regions. For web-app expansion,
the markup includes a margin on the side that would consist of each residues number, and note
proteins stating position.

numbers represent each row of proteins. The "residue number" section, outlined in
yellow, and the down arrow illustrates placement for where this markup enhancement
would fit for each block of rows. Including a legion, with the residue ranges is
complicated because it will require document look-up for each protein file submitted for
alignment. To elaborate, we focus on another markup in Figure 3.1. We also have noted
value in adding labels that state the residue start number for each protein. The tag is
beneficial since some proteins don’t start at residue one. Some experimentally
documented proteins might start at say a tenth or fifteenth residue even. We can tag it
with a label, as pictured, and refer to it as the "starting point for each protein."
The benefit of this change organizes information and allows for a smoother
pipeline to represent the transition from conserved core regions to ADS. Recall, that to
confirm if a location is indeed an active-sites, we use biologically confirmed information
for testing. Looking at the yellow circled conserved regions again noted in Figure 3.1 (the
enclosed stars), we can highlight each star from the conserved core that is also
biologically confirmed to be an active-sites. Collectively, these changes are advantageous
for training as we conduct our studies and will make our methodology for ASD more
robust. In our training stages, we use these changes to create a notation for documenting
and tracking our research.
3.2.3B msTALI ASD Submission Capability
msTALI utilizes PDB files for structural alignment. There are three approaches
users select to perform alignments: core, flexible, and custom. Core alignments are the
default and provide a rigid adjustment resulting in the maximum conserved region at a
minimum cost. The flexible option offers more fluid incorporation of parameters –
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Figure 3.2 Job Submission Options for msTALI. Step three of submitting a job to msTALI for structural alignment
requires users to select an option that best fits their needs. The approaches then output results based on the input.
Each method also needs to be evaluated for active-sites studies. Here, we depict the help menu which outlines what
each option does.

that promotes the proper alignment of movable portions of proteins. The custom option
provides a configuration file template suitable for specific user needs; individual settings
are set [19]. Users can use the help menu to explain these differences before submitting
jobs as shown in Figure 3.2.
Our studies apply the core approach. Still, it makes sense to explore additional
approaches. It is possible that custom parameters work best for such studies. Thus, job
submission formatting is essential. We are prepared to include alignment approaches
specific to each functional studied classification. For example, we propose an interface
that enables ASD study functionality based on the target proteins mentioned in Table
1each class would then have a templating feature notably how our original core, flex, and
custom approach display. With ASD, user submission would include a protein with our
defined classes, with the objective of it fitting the motifs categorized by each studied
functional group. When a protein does not contain the motif we will deem it inconsistent
for the selected function. Observing these possibilities will expand and strengthen our
methodology.
3.2.3C msTALI ASD Output
The output page for msTALI includes sequence information as mentioned in
subsection 3.2.3A, a visual representation for the structural alignment of all proteins, and
a phylogeny tree. Current structural descriptions display two images; one image
illustrates the arrangement of each of the proteins collectively, the second image is a
secondary structure representation showing the alignment of the conserved core region.
These images are rendered using JSmol [27]. With our observations, we provide markup
visuals using VMD [26].

30

31
Figure 3.3 ASD from msTALI Results. Pictured is protein 1A2B from our fold family protein study. Selection A displays the protein
itself while highlighting the conserved core region obtained from msTALI. Selection B illustrates the conserved region with a surface
representation alone.

The msTALI results aid in the images produced. We then use biologically confirmed
information in PDB, and our pseudo-manual process to generate images for ASD.
Pictured in Figure 3.3 is an example of our VMD rendition.
Further, we establish the conserved core region for its position within its
corresponding protein. For these studies, we aim to utilize the conserved regions, and the
overlapping biologically confirmed active-sites to generate output beneficial to users that
would like to notate or make images similar to that of Figure 3.3. In instances where the
established active-sites differ from the msTALI ASD conserved regions, one can merely
color code the specific residues and label them for comparison.
With our phylogenetic results, msTALI generates a phylogenetic tree [19] when
performing a structural alignment. With our ASD approach, we use this tree, annotate it,
and produce addition alignments on subset groupings of branches, within the tree, and
based on relative clustering. This process generates sets of conserved core regions. We
use the collections of conserved core regions to categorize all lucrative areas for a
functional class of proteins. Again we validate using biologically confirmed annotation
and then classify our functional motifs for our ASD approach. We display the original
msTALI output phylogeny tree transitioning to the markup/ annotated tree in Figure 3.4.
The overall incorporation of an ASD output for msTALI provides users with
details from our approach. Alignments based on each studied functional group need
return output that includes the conserved core residues for an ASD functional motif, and
the motif characteristics.
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Figure 3.4 Phylogeny tree Annotation. Each instance of a msTALI run for structural alignment generates a
phylogeny tree. This analysis is useful, and for active-sites identification studies we incorporate an additional
markup, based on CATH classification. The annotated tree serves well for ASD testing. The example here is
from our fold family study. From the example, our annotated tree can explore the option of colored branches
as circled for a cleaner look.

CHAPTER 4
UTILIZING MSTALI FOR ASD
Servicing msTALI for ASD relies on the functionality of the proteins observed.
Further, our initial premise states that if proteins perform the same function, then there
are structural similarities – amongst other things – that must remain consistent amongst
that set of proteins. The question then becomes, how do we quantify and qualify which
similarities are relevant? Which similarities found, if any, are coincidental? Or, even,
how do we go about automating a process to answer these questions accurately? Proteins
support our studies with biologically confirmed similarities. We then use our approach
and diverging qualities in the proteins to produce meaningful results. The novelty comes
from the msTALI capability for performing multiple structure alignments on sets of
proteins simultaneously. This chapter describes our overarching approach for ASD and
lists relevant work. We examine the information from studies that evaluate msTALI as
suitable software for active-sites analysis. The first study includes proteins that are
biologically confirmed to exhibit ATPase activity in observance of a previous structurebased comparison method. The second study targeted proteins used to evaluate our
approach's performance using three different protein families for a comparison study. We
then report our primary findings and expand to current application studies.
4.1 METHODOLIGCAL DEVELOPMENT FOR ASD USING MSTALI
From our initial premise, the framework for our ASD using msTALI is initiated
by establishing the use of its features. Recall that an aspect of our approach's novelty –
34

stems from the ability to align multiple proteins simultaneously and to consider how we
perform alignments. To this point, the bulk of this section addresses two features:
1. Target Protein Selection; with selecting targets for any given study, we know their
function and consider this a tight prerequisite. Directly, there wouldn't be a case
where proteins are aligned if their classifications were not relevant to a protein or
class of proteins intended for ASD studies. This notion ensures that our ASD studies
incorporate a focused similar to experimental solutions that use docking constraints
and chemical interactions and solutions for detailed studies [28]. If relating to
computational approaches, target selection is analogous to surveying an entire
proteins surface area or other pre-processing/ calculations accepted by the community
[29]
2. Mode of msTALI alignment; with the alignment of proteins, there are essentially
three options for alignment. Core, flex, and custom. The latter portion of this section
describes the alignment settings we use. Previous developmental descriptions
describe the modes for msTALI [19]. Ultimately, the settings affect the weights
applied to our equation in section 3.1, whereby their incorporation establishes the
score and proteins residues considered conserved.
With the features outlined, we set a framework for the build of our approach to ASD. We
answer the questions addressing their effect. For example, with target proteins, are
different results observed based on proteins aligned, and to what degree? How many
proteins are required to provide promising results for ASD studies? Why might one
alignment setting fare better than any counterpart settings? From answering these
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questions, a lucrative context is derived for features. Our methodology is described, and
we address studies supporting our hypothesis.
4.1.1 Target Protein Selection and the Effect on Alignments
Most notably, proteins undergoing an ASD using msTALI serve a similar purpose
or essentially have the same function. However, since we deem this a strict prerequisite,
there is value in discussing the effects of more significant dissimilarity for targeted
proteins. We want to describe how we still yield useful information when the aligned
proteins' function is not directly the same. Further, we provide an example as applied to a
novel protein with little annotation. For a detailed description of this study, we refer to
section 4.2.4A. This section focuses specifically on the targeted group effect. Discussing
the ASD for a novel protein in this section captures how even with underrepresented
information, our ASD descriptions are valuable. For example, if we align a group of
unrelated but highly annotated proteins, then compare to a protein we know performs
some function, and evaluate using our approach, we'd expect that even with imprecise
results, we still have a larger pool of information to consider. There is a larger chance for
coincidental similarities in such cases.
Our exampled protein has less documentation. Both the available and applicable
information relates to its function and proteins known to function like it. The functional
context is gathered from experimental understandings classified but not readily annotated
for function [30]. Consequently, we align the protein with a group of proteins that foster
its role through interaction/ reaction. We are nearly using proteins that our novel protein
binds or interacts with. We also align the same said novel protein with a separate group
of proteins known to function similarly. We observe 44 residues and 35 residues from the
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two comparison groups, respectively. Typically these conserved residues would describe
the relevant structural components that facilitate function and are prominent for said
protein to reveal the active-site [31]. However, even though the 44 and 35 sets of residues
are close in numerical range, we observe that these sets are roughly only 20% the same.
An 80% difference is not beneficial to ASD directly. The discrepancy between
similarities and differences supports that target protein selection serves to be selective.
To establish our prerequisite and increase its constraints, we explore how the set
similarities and differences are useful. For example, we observe the differing conserved
residues to see what is relevant (from the eighty percent differing). In these instances, we
find that roughly 86% of residues demonstrate structural importance, functional
importance, and or are believed to account for active-site regions. Annotation is easily
attainable using our method, and areas causal to function are uncovered [30]. None the
less, for ASD combining the conserved residues, provide a more robust annotation for the
novel protein. This highlights the prerequisite for target protein selection and makes our
hypothesis complete for use.
Evidence suggests that when a disjoint set of residues is obtained from the target
protein selection of different interests, there is enough annotation information. The
notable residues are not random false positives. We attribute the consistent relevance of
detectable residues to the functionality of the msTALI algorithm [19]. We see that the set
alignments' similarities lead to strong structural correlation but may span only a small
protein area for ASD. Additionally, when conserved residues are different based on the
set alignments, there are components that we cannot merely disregard due to the potential
for annotation; they're helpful too.
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Moreover, since each set has relevant information, target proteins must be
selected to minimize the range of similarities and differences for any alignment set. We
accomplish this by incorporating a tight prerequisite that all proteins observed for our
ASD have some structural diversity and are confirmed to perform the same function. We
adjust for set similarity disparities by including a good enough sample size of aligned
proteins.
4.1.1A Target Protein Sample Size Expectation for ASD
Target protein selection is also addressed based on the number of proteins we
incorporate for alignment. We take advantage of the msTALI ability to align up to twenty
proteins at a time [19]. Here we summarize the effects from multiple studies, in short,
concerning the number of proteins used. Twenty proteins are our upper bound. We
discuss our lower bound based on how well we can use our ASD technique with fewer
proteins. We want to ensure that we have aligned several proteins directly beneficial to
ASD as a prerequisite.
4.1.1Ai Bound Establishment for Target Sample Size
Preliminary studies outlined in section 4.2.1 focus on msTALI ASD for ATPase
studies. Targets were selected based on the complexity and flexibility in the ligandbinding for activity [32]. For the early establishment, we first aligned our target sets
simultaneously, whereby we acknowledge eight residues being critical for this class of
proteins' function. Still, we have to determine how much of these motifs are causal to
function, are of structural importance, have binding qualities, or are confirmed as actual
active-sites. We expand the study by aligning sets of proteins pairwise. Aligning two
proteins is not tight enough to validate our hypothesis. For example, as many as 255

38

residues were conserved in instances of these cases. With an average protein length of
roughly 333 residues for the protein study, we'd be accounting for approximately 77% of
the protein. If we were to establish the encompassed residues as an active-site, there
would be overfitting surely. To expound on this perspective, the smallest protein in the
study had 159 residues. Using this as a reference, we further express an extreme overlap/
overfitting in critical residue observation. Two proteins exhibiting the same function find
enough information to characterize active-sites, but it also includes far too many details.
With too many details, oversaturation occurs to a degree where a whole protein becomes
categorized as causal to function. As standard, this is underwhelming and incorrect. Now
the understanding calls for boundaries for our sample size in alignments.
Providing a large quantity of information for conserved residues does not always
establish the primary conserved residues for ASD. We have to discuss the sensitivity
required for selecting target proteins systematically, which supports the importance of our
tight prerequisite. We do this by observing the number of proteins aligned across studies
for ASD based on how many conserved residues we keep with each instance. We simply
ask how many residues were conserved when aligning two proteins in this case. We
move forward evaluating those residues conserved in this other case, with three or four,
on to thirteen, and upwards toward our ceiling groups with roughly twenty proteins
aligned simultaneously. Through approximately 200 studies, we have charted the number
of conserved protein residues outputted from msTALI studies for ASD. Both the
diverging and converging/ similar qualities in protein structures affect ASD using
msTALI, so does the flexibility in binding for each studied function. Despite these
intricate details, lucrative representations for ASD across the studies are in Figure 4.1.
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Each study's observations are outlined and categorized by the number of aligned proteins
in conjunction with the protein residues returned and the average residues across sets.
4.1.1B Charting the Sample Size of Targets
Figure 4.1 illustrates the number of proteins aligned for ASD across studies. The
quantities are plotted with the number of conserved protein residues returned for each use
of msTALI. The threshold line and the protein alignment averages explain our
requirement for target protein selection. Elaborating, we now can say ‘n’ proteins
valuably characterize the motifs recognizable for a studied function – where n is a
number.
We state that our Threshold is 55 residues. This Threshold is reliable and
established based on a percentage of the average length of proteins studied. Further, we
report the following: if the average conserved residues returned from a study are above
the Threshold, they are less fitted to our prerequisite and impractical for ASD. Our
findings suggest that an accurate ASD study using our approach requires a minimum of
five proteins aligned simultaneously.
Graphed in Figure 4.1, when two proteins are aligned, the conserved residues'
number approaches our Threshold more quickly. We've discussed this and how it leads to
oversaturation. When two proteins are aligned, sixteen observations were over the
Threshold, and the average number of residues is 83, which is also over the Threshold.
Aligning three proteins resulted in six exceeding instances with an average number of 57
residues. With four proteins, the Threshold is surpassed seven times, and the average
number of residues is 49. When five proteins are aligned, three observations were over
the Threshold, and the average number of residues is 27. When six or more proteins are
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aligned, two observations were over the Threshold, and the average number of residues is
15. By assessing these charted values, the sample size prerequisite for target proteins is
determined. Also, the range of returned residues and the accuracy of relevant regions
maintain our required input for ASD.
4.1.1Bi Verifying the Sample Size of Targets Simultaneously
Here we discuss how we arrive at our minimum sample size requirement for
ASD, particularly for simultaneous alignments using msTALI. The simultaneous
component is notable since it is the foundation for establishing motifs for protein function
in studies. Our interpretations lead to additional points significant in verifying how we
methodically arrive at minimally using five proteins for ASD. For starters, we clarify
why alignments using three or four proteins for simultaneous studies are not enough.
Provided our Threshold, it's directly evident that three proteins fall short of the ideal.
Table 4.1 highlights that with four proteins, the average conserved residue count is less
than the Threshold. However, notice that there are more individual observations above
the Threshold with four aligned proteins than those with three aligned proteins. We use
Table 4.1 again to disambiguate how the simultaneous alignment for three of four
proteins is worse for ASD. Column three introduces the numerical range in values for
conserved residues. Specifically, reporting the span of regions to limit its variation.
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Figure 4.1. The Numerical Requisite for Proteins Aligned with msTALI. We plot the conserved residues based on the number of
alignments we observe. We use the details to determine the how many aligned proteins produce meaningful results when applying
msTALI for ASD. Each line outlines the number of residues reported when aligning a certain amount of proteins together. The Average
marks how many protein residues are typically reported when the said number of proteins is aligned. We aim to have averages below
the threshold line.

With two proteins aligned, the range is 278, and for both three and four aligned
proteins, the range is 230 residues. Additionally, we see that for instances where five
proteins are aligned, each column criterion fits our tight prerequisite for target protein
selection; the observations are under the Threshold and have a range spanning 173
residues. Further, with few instances above the Threshold, we can reason that
simultaneous use for ASD is consistently lucrative – even the percentage of a threshold
breach decreases roughly in half. Now we confidently state that any study that aligns
more than five proteins will achieve our standards. Again, from Table 2, and across the
board, the Threshold isn't overrun, and the range for conserved residues is 66. Explaining
why when alignments included six or more proteins for simultaneous use, we categorize
the results together. The tabled examples use these cutoffs to assure further that returned
residues support our approach to ASD.
Essentially, we declare five proteins, again, as our minimal prerequisite quantity
suitable for aligning target proteins for lucrative ASD studies. The methodical highlight
of returned residues for examinations, the range in values, and the instances against our
Threshold illustrate the decrease in our set studies' oversaturation. We use the grouping
of six or more proteins to emphasize our continuing trend and standard. Elaborating, we
demonstrate how counting up from two proteins aligned together, that at five proteins, we
notice the most significant change in trend. Counting up need not continue since, with six
proteins, our trend is maintained, and onward is consistent to our base. To this point, we
emphasize our finding with an example study that also highlights accuracy in ASD.
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Table 4.1 Protein Alignment Count. This table highlights the values shown in Figure 4.1.
Featured are the average number of residues and the range distribution of residues for each
observation compared to the Threshold. Column four lists how many instances across the
study set were above the Threshold. Collectively, these tables pinpoint that five or more
proteins serve as a tight prerequisite suitable for ASD.
# Proteins
Aligned in Study

Average # of
Returned Residues

Residue Range
Distribution (#)

Instances Over
the Threshold

Three Proteins

57

230

6

Four Proteins

49

230

7

Five Proteins

27

173

3

Six+ Proteins

15

66

1

4.1.1Bii Utilizing a Minimal Sample Set of Target Proteins
There are critical criteria considered for ASD applications with msTALI. In
outlining our approach, a prominent aspect is our prerequisite for target proteins in the
study. We use the conserved residue count, range of the residue values observed, and
thresholds to assess how reliable targets will be in practice for yielding motif
characteristics. We understand that several features affect or potentially skew the
conserved residues in exploring these criteria for selection. Namely, the protein structural
similarity, function, and any additional binding cofactors describe some such features.
These components all highlight the complexity of the problem. Each part is directly
incorporated with our approach. Still, to harden the claim for a five protein minimum
prerequisite, we exemplify a study that builds target protein selection topics with
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accuracy in ASD. The detail for this class of proteins is in section 4.2.3. An overview as
applied to our targeting sample size is outlined here.
A study to address steroid proteins' function utilized five proteins studied initially
[20]. We apply this example as an ideal case since it addresses a prevalent class of
protein function with defined characteristics accepted as targetable for studies. They also
added to the overall list of proteins we used, with a point of reference. Further, exploring
the set strengthens our sentiments regarding a five protein minimal prerequisite for our
approach. We compare our use of target proteins 1E3R, 1FDS, 1J99, 1LHU, and 1QKT
with our alignment descriptions for all of our studied proteins that aligned five proteins in
Table 4.2 Columns two through four mirrors the layout found in Table 4.1 as a point of
reference. We see that for our steroid class of target proteins, the overall average number
of returned residues is higher than the same measured criteria for our studies conducted
by aligning five proteins in general, 53 and 27 returned residues, respectively. Notably,
from Table 4.2, both the residue range distribution and instances over our mentioned
Threshold were less for our steroid study. The value 62 is substantially less than 173
when five proteins are aligned in general. Two is less than three, and to this point, for our
alignment of five steroid targets, the distribution and Threshold comparison agree more
closely to instances where six or more proteins were aligned. This is not the case when
reporting the average number of returned protein residues. There is a valuable
explanation for this finding.
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Table 4.2 Comparing Alignment Descriptions. Here we compare our steroid target protein
study with our general studies that use five protein alignments. Column two highlights the
average number of returned residues, column three the range of residues observes, and the
fourth column list how many observations exist over our Threshold for residues in studies.
Alignment
Description

Average # of
Returned
Residues

Residue Range
Distribution (#)

Instances Over
the Threshold

Steroid Class

53

62

2

Five Proteins

27

173

3

Aside from the returned residues, we notice that all criteria visibly follow the
trend for our arrival at a five protein minimal prerequisite in approach. The steroid-based
target protein studies support our observation. To explain the exception, we look first to
Table 4, which lists the returned residues for each of our five target proteins. They
account for the average reported in the previous table for the steroid class. Specifically, it
is pivotal that we describe that even though our standard returned residue count of 53 is
larger than the general 27, that 53 is indeed less than our Threshold of 55 residues.
Column two of Table 4.3 lists each protein's conserved residue count. Further, we
consider our comparison to the alignment for five proteins in general as an average of
values. Essentially, understanding that across several studies, some conserved residue
counts are larger and others smaller. This case is mainly higher, and if we use another
comparison – just for referential discussion – we are closer to the general outlook than it
appears. For example, if we consider the five studied targets' residue count mode, for the
average, 29 is closer to 27.
Nonetheless, more valuable than empirical closeness in numbers explains why
this instance is averaged higher than five proteins used generally. To this point, column
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five of Table 4.3 is helpful. We included C.A.T.H. classification for each of the five
target proteins. As an acronym, the Class, Architecture, Topology, and Homology
expound on structural variety, and each number is period delimited to represent each
corresponding letter of the abbreviation [25]. Recall that outside of our criteria assessing
requirements on targets, we discussed features that affect results. Structural similarity for
proteins is one of them; it affected these results and contributed to the difficulty in
addressing problems in ASD outright. Table 4.3 depicts two proteins having extreme
similarity in the structure up to their topological classification. Proteins 1FDS and 1J99
are classified as 3.40.50.720 and 3.40.50.300, only differing in homology [25]. Therefore,
it is not surprising that these two proteins have higher returned conserved residue counts
of 91 and 76 across the target set. These account for the two proteins above the Threshold
shown in Figure 4.2 and are causal to the rise in the average number of returned residues.
We've collectively outlined correctness in our criteria for evaluating our minimum
sample size for simultaneous alignment of target proteins for ASD. The study conducted
on five steroid proteins proved ideal, highlighting that five proteins are suitable for a
minimal target study of proteins for ASD. Notably, from Table 4.2, we see results’
showing how simultaneously aligning six or more proteins is sufficient (the residue range
number is closer to when six proteins are aligned). From Table 4, we reason how
structural similarity affects alignments, and those five proteins afford just enough room to
remain consistent with our findings. Our C.A.T.H. referencing supports this. For
consistency, graphing Figure 4.2 illustrates how we still satisfy our criteria despite our
returned residue count being more extensive than the identifiable generalized count. Our
average returned residues are under the Threshold of 55 residues with our steroid class of
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studied proteins. The two instances do not skew the prerequisite. Instead, they support
our claim, emphasize the intricate nature of selecting target proteins, and verify that
outside the minimal for ASD, our approach continues to show accurate descriptions. As
mentioned in section 4.2.2, this study roughly recalled 70 percent of the proteins' activesites with approximately 40 percent precision score, both of which we describe as
successful [31]. Thus, our targeting approach accuracy isn't compromised, and we can
address how we align proteins for our approach. We've established a legitimate ground
for connecting the available – frequently – experimental information with our
computational approach. The proteins aligned for a study matter. They directly impact
results beneficial to ASD. We note that an improper selection of target proteins still
returns structurally essential information with other useful anecdotes. Products are not
just categorical for ASD in that case; this attests to the msTALI algorithm.
Table 2.3 Recording Conserved Residues for Steroid Targets. Here we list the specific
number of residues returned for each observed protein and use structural similarity to
address threshold inclusion. The reported residues and distribution describe how our values
from Table 4.2 were generated and compared to results where five proteins are aligned.
Target
Proteins

Returned
Residue count
(#)

Residue Range
Distribution
(#)

Instances
Over the
Threshold

C.A.T.H
Classification

1E3R

29

62

2

3.10.450.50

1FDS

91

62

2

3.40.50.720

1J99

76

62

2

3.40.50.300

1LHU

44

62

2

2.60.120.200

1QKT

29

62

2

1.10.565.10
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Figure 4.2 The Requisite Description on Steroid Functional Class. The plotting of conserved residues is reported based
on the number of alignments we observe for our five protein steroid-based set study. We plot our valued examples from
Table 4.3 to see how consistent our steroid example fits the observations from Figure 4.1.

Our approach establishes a tight prerequisite of minimally five target proteins. We arrive
at this conclusion by assessing the protein residues highlighted for being conserved
across each study. By quantifying results when two proteins are aligned, to three, to four,
etc., we establish a trend that suggests the five proteins are indeed our minimal
prerequisite and use six proteins or more as our standard (not exceeding our calculative
bound of 20 proteins with msTALI).
4.1.2 Establishing our Setting for Alignment
Our target protein selection and the number of targets used for ASD are
incorporated in our approach and backed by study trials. For this section, we discuss how
we conduct alignments. The mode of alignment used for our method is the second feature
required for relevant results. Again these are settings within the msTALI engine
highlighted in Figure 3.2. The alignment settings are core, flex, and custom. We address
the comparison for these settings speedily since we review the output of studies directly.
Again, we are essentially performing structural alignments on target proteins while
adjusting parameters that allot for weights catering interest when utilizing these options.
Core msTALI alignments serve as the default alignment setting by conforming to central
backbone atoms. This instance is a greedy approach for maximizing the aligned protein
residue count while minimizing/ maintaining a low threshold for the backbone RMSD
across the observed proteins. Again, we recognize Eq. (1) for facilitating the iterations
necessary between increasing core size and decreasing RMSD to achieve superior
structural alignments [19]. The core alignment result is indeed the conserved residues
amongst the structures – essentially having the highest scores. As mentioned, it is the
collection of the conserved residues that are then used for ASD. Comparatively, the
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difference between core and flex alignments is the emphasis of Eq. (1). For core, it's
geared more towards Cα distances, and for the flex, focus lean toward side chain features,
which are less rigid. Flex constraints allot for more matched structures and essentially
more conserved residues. With custom settings, weights can be adjusted for a particular
task/ interest applied to the wrapper and used to conduct alignment. We are less
concerned by this option as the comparisons between the core and flex are
overwhelmingly evident. Further, optimizations for flex components aren't primary, but
instead, an aim contingent on results deemed unsuitable. Our approach to ASD based on
the core alignments was examined and confirmed ideal.
To evaluate the effect of core alignments to flex alignments, we simply list values
obtained from their use in msTALI. We provide the alignment listing for several amounts
of proteins together. We explored pairwise examples, and all other values adhere to our
minimal or better approach for protein target selection. The same proteins are used for
each test, whether there are two proteins aligned or nineteen. We report the number of
conserved residues resulting from a core alignment and the respective flex alignment in
Table 4.4. The comparison overwhelmingly corroborates our use of the core engine.
From core to flex, we see an average percent difference of roughly 150 percent, and
clearly, there are listed examples upward of that.
Explanation making core use more suited for our approach to ASD is accuracy.
The residues conserved using flex constraints are too fluid and return far too many
residues. We experience extreme overfitting with flex cases. For example, even with test
four, we see nine conserved residues while the flex has forty. This is only for the
simultaneous alignment for that set of targeted proteins. With our method, we then have
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subsequent alignments and aggregate the conserved regions for ASD. The number of
residues for an overall ASD with the flex settings surge quickly. With test four, if the
next alignment had similar results, and doubled, then reports would suggest eighty
residues, which in most cases constitute a large portion of any given protein. All of the
flex examples from Table 4.4 exceed and are quickly approaching our Threshold for
residues to accurately describe an ASD section 4.1.1Bii. With such, precision and recall
values become impractical. Similarly, we've established having target sets with fewer
proteins than our minimal criteria does the same for accuracy. Test one reinforces this;
even the core alignment is pressing our Threshold.
Our claim acknowledges that the flex mode for msTALI is beneficial. It's most
reliable when less rigid alignments are needed for structural motifs fringing from central
backbone locations, areas heavily based on sidechain conservation. The inclination
suggests that flexible representations would capture more of the dynamic characteristics
of tethered to function. However, the option is too loose for ASD. Our structural
alignments are superior due to feature incorporation.
Consequently, addressing ASD is best suited by alignment with strict conditions.
The evidence supports the core mode for ASD; it's rigid in its emphasis on Cα distances
for protein residues. We account for flexibility or the more dynamic nature of function by
incorporating our target protein selection process. Therefore, the combination of a rigid
alignment on same-functioned targets serves the most sensitive to ASD conditions. By
addressing target selection features and the msTALI alignment method, we commit our
approach to more studies.
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Table 4.4 Comparing the Mode of Alignment for Proteins Studies. This table list the
number of conserved residues reported for sets of proteins as it pertains to their mode of
alignment. Each test uses the same proteins to compare the core and flex alignment
convention for the said number of proteins aligned. The objective is to have a lower amount
of conserved core residues for well-formed ASD.
Example
Test 1
Test 2
Test 3
Test 4
Test 5

Number of
Proteins Aligned
2
5
9
13
19

Mode of msTALI Alignment
Core (res)
Flex (res)
43
165
15
264
8
134
9
40
8
59

4.2 APPLICATION TO STUDIES THROUGH MSTALI
We examine the information from studies that evaluate msTALI as suitable
software for active-site analysis. The first study includes proteins that are biologically
confirmed to exhibit ATPase activity in observance of a previous structure-based
comparison method. The second study targeted proteins used to evaluate our approach's
performance using three different protein families for a comparison study. These more
preliminary studies then fuel our developmental analysis of several critical enzymatic
activities. Here, the objective is to collect proteins classed by their primary function,
which we then have established crucial amino acid residues for an ASD. The section ends
with current studies employing our method for ASD to real-world instances with SARSCoV-2 based viral proteins. Collectively, these studies provide information prime to
advancing the engine for ASD. We directly address the focused questions from the
proposal of our methodical development.
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4.2.1 Utility of ATPase Study
Our first structure-based study for active-sites relied on the analysis of 19 proteins
with certain ATPase activity. The basis for selecting these proteins relied on three
contributing factors: previous work for comparison purposes, structural diversity, and
complexity of the problem. These 19 proteins were subject to an earlier analysis using
Continuous Optimization (CO) [8] and Molecular Local Surface Comparison (MolLoc)
[33].
Analysis of ATPase proteins is compelling in two additional aspects; protein
dissimilarity and ATP's structural flexibility as a substrate. The diversity of proteins that
exhibit ATPase activity renders this problem particularly challenging and meaningful to
address. Table 4.5 lists the 19 target proteins with some of their binding properties.
Column two describes the organisms associated with each protein and highlights many
organisms, ranging from wild boar to human flu. Further, columns three, four, and five
highlight diversity in the residue length, ligand, and metal cofactors associated with each
protein, respectively. There is no single protein described by having a single ligand
interaction; in fact, some have as many as four, and cofactors range from Sulfate to
Lutetium. Structural diversity among these 19 proteins also constitutes a unique feature
of this problem. As mentioned, we also highlight some of the structural properties of the
target proteins. The sixth column shows the difference in C.A.T.H. classification [25]
even. This, in turn, describes variation in chain and domain characteristics for each
protein. Some proteins are primarily helical, others beta-strand, and others mixtures of
both; Table 4.6 provides cartoon rendering of these 19 proteins to highlight their
structural diversity further.
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The Structural diversity of these proteins while maintaining primary ATPase
activity is central to our study. This problem's difficulty affords analysis descriptive
enough to convey what our msTALI system can withstand and what potential anomalies
manifest when applying to ASD. Here, we grasped additional insight into the sensitivity
to incorporate when aligning multiple proteins for ASD. The challenges faced by
studying ATPase activity pioneered our understanding of managing a grouping strategy.
They proved tonal for the simultaneous and subsequent alignments performed for the
successful aggregation of conserved residues. We addressed target protein use with
greater detail in section 4.1.
Our application of msTALI for active-site identification successfully identified a
motif characteristic of ATPase activity. Additionally, we report the successful
identification for the ATPase active-site complex documented for 1ATP-E while
adhering to our phylogenetic analysis conventions. We specifically address how eight
residues obtained from the study's simultaneous alignment are leading-edge for building
the overall ASD. Figure 4.3 displays our msTALI identified active-site, and the
biologically confirmed active-site for the protein 1ATP-E. Figure 4.3A highlights the
biologically confirmed active-site and Figure 4.3B the conserved core residues we
produce. Residues in common are shown in Figure 4.3C. Figure 4.3D shows the
superimposed relationship of A, B, and C.
Further, we attained far superior conserved regions in comparison to CO and
MolLoc [32]. Also highlighted is our reporting, which is consistent with amino acid
residues instead of atom-based representation. This is more consistent with
documentation. It reduces computational rigor concerning atom-to-residues conversions
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with geometric constraints while valuing that residues conserved occupy more physical
space for proteins. All of which are useful for evaluating studies and for aiming to build a
streamlined standard approach.
Table 4.5 ATPase Target Protein Overview. We describe Target proteins by the organism,
the ligands, and metal complexes they bind. *1.Methanocaldococcus Jannaschii
*2.Thermococcus Kodakarensis
PROTEIN

ORGANISM

LIGANDS

METALS

1A82

E. Coli mutant

ATP, DNN

MG

1ATP-E

House Mouse

ATP

MN

1E2Q

Human TMPK

ATP, TMP

MG

1F9A-C

M. Jannaschii*1

ATP

MG

1JJV

Human Flu

ATP, SO4

HG

1KP2-A

E. Coli

ATP, GAI, PO4

NONE

1MJH-A

M. Jannaschii*1

ATP

MN

1AYL

Plant E. Coli

ATP, OXL

MG

1B8A-A

T. K.*2

ATP

MN

1CSN

Fission Yeast

ATP, SO4

MG

1E8X-A

Wild Boar

ATP

LU

1G5T

Salmonella

ATP

MG

1GN8-A

E. Coli

ATP, SO4

MN

1HCK

ATP

MG

ATP, ACT, HEZ

CO

1KAY

Human
Thermotoga
Maritima
Cow

ATP

MG, CL, K

1NSF

Chinese Hamster

ATP

MG

1YAG

Human

ATP, SO4

MG

1PHK

European Rabbit

ATP

MN

1J7K
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Table 4.6 Secondary Structure for ATPase Target Proteins. Here includes the cartoon
rendering of the 19 target proteins, all of which are confirmed to have ATPase binding
activity. Further, the table illustrates the diversity in structural components for each protein.
1A82

1ATP-E

1CSN

1E2Q

1G5T

1GN8-A

1JJV

1KAY

1AYL

1B8A-A

1E8X-A

1F94-C

1HCK

1KP2-A

1PHK

1NSF
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1J7K

1MJH-A

1YAG
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Figure 4.3 The active-site for 1ATP-E. A. The confirmed residues for ATP
binding as documented from the PDB. B. Illustrates conserved core residues
responsible for ATP binding as output returned from msTALI. C. The
overlapping areas common from representations A and B. D. The active-sites
are rendered in respect to one another.

4.2.2 Utility of Fold Families for Evaluation
We've established that our approach to ASD produced meaningful results. Better
again, our preliminary studies applied a difficult, more flexible functionality in ATPase
activity. In turn, the evaluation of the method is essential. Here we use proteins with
more similar structural composition and functionalities to discuss accuracy. We note that
a high structural similarity amongst the set constitutes a different degree of difficulty.
The high similarity between protein structures lends to more conserved residues and a
higher possibility for overfitting. Overfitting is not suitable for the overall ASD.
However, we accept the readily available documentation to evaluate accuracy. We
simply apply our thresholds for returned residues (based on protein length) to disregard
non-important features for ASD to address the high structural similarity. Further, with
prevalent documentation and details from the previous studies, we verify evaluation in a
base case format.
Our structure-based identification of active-sites relied on the analysis of 15
proteins. Selected based on previous reports and method comparison [18]. The proteins
are classified into three families of enzymatic activities: G proteins family in P-loop
folds, PYP-like family in Profilin-like folds, and FAD-linked reductases family
FAD/NAD(P)-binding folds. The G-domain and Ras superfamily are well known [34],
profilin is widely studied for cellular activity [35], and the same holds for analysis of
FAD based proteins [36]. Our evaluation starts with assessing our target set's
relationship since we know that we are using a lucrative amount of targets for ASD. In
Figure 4.4, we illustrate the structural similarity across each fold family. Our structural
alignments through msTALI are supported in P-loop folds, Profilin-like folds, and
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FAD/NAD(P)-binding folds, with 173, 119, and 495 conserved residues with backbone
RMSD values of 1.30, 0.43, and 0.69 angstroms, respectively. Considering each
corresponding protein fold family's average length is roughly 184, 124, and 505 amino
acids long; our proteins are indeed structurally similar. In any of these cases, the
structural conservation isn't sensitive enough as we return between roughly 94 – 98
percent of the structure. To this point, we employ our technique of aligning all of the
proteins together simultaneously, not exclusively by their fold family. We then use the
subsequent alignments in conjunction with our simultaneous conserved regions to
address ASD and our evaluation focus. There isn't an all-inclusive analysis metric for
ASD, but several adapted models to reference documentation available in databases of
interest. We use PDB. For our comparison, we use two factors; precision and recall, as
previously reported [18]. We employ Eq. (2) to quantify precision. Where precision is a
percentage comparison of residues returned, consistent with confirmed documented
findings.
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =

𝐴𝑆𝑚𝐶
⁄𝐴𝑆𝑚
𝑀

(2)

Here, ASm refers to the actual number of active-sites obtained from the method; in
our case msTALI. The subscript, C denotes returned active-sites from the technique that
are confirmed as active-sites. The subscript M denotes actives-sites that are simply
measured and outputted by the method. Secondly, we use Eq. (3) to quantify recall,
which incorporates Eq. (4) to obtain our value. The recall is used to track the overall
amount of active-sites discovered outright through our method.
𝑅𝑒𝑐𝑎𝑙𝑙 = 𝑀𝑆𝑝 − 𝐸𝑟𝑟𝑜𝑟 𝑆𝑐𝑜𝑟𝑒
𝐸𝑟𝑟𝑜𝑟 𝑆𝑐𝑜𝑟𝑒 =

(𝐴𝑆𝑚𝑀 − 𝐴𝑆𝑚𝐶 )
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𝐴𝑆𝑔𝐶

∗𝜀

(3)
(4)

Here, MSp refers to the maximum number of active-sites that can be recovered,
total coverage being 100 percent. We define our error score as the penalty evaluated from
our precision. Whereby, the 𝜀 multiplication addresses how great of a penalty factor we
allot. The value 𝐴𝑆𝑔𝐶 is the represented number of confirmed active-sites documented.
The reported evaluation is in Figure 4.5. We list the G proteins family in P-loop
folds, PYP-like family in Profilin-like folds, and FAD-linked reductases family in
FAD/NAD(P)-binding folds, and highlight them respectively; purple, green, and red. As
mentioned, we compare our evaluation to BsFinder, and several others by association
based the precision and recall. Before looking forward, we note the size of the proteins.
Our largest proteins are documented as not exceeding 4000 atoms in length, and the
largest recorded active-site size does not exceed 260 atoms. Henceforth, any reported
values that exceed these thresholds use a representation subject to overfitting.
We declare that there are inconsistencies with reporting. Approaches do not have
a unified reporting convention. Some use atomic representations as opposed to the
amino-acid residue. Our aim is a more applicable reporting evaluation. We disambiguate
any atomic and locational constraints by using purely documented residues for each
protein. Figure 4.5 the column heading with "Numbers" for each method (columns six
and eight) demonstrates how such inconsistencies result in drastically different charting
for the number of found active-sites. The results at first glance could be misleading.
Consequently, we translate our protein size to the number of atoms for both the
protein and its active-site size. Columns three and five of Figure 4.5 report the confirmed
corresponding length in atoms. Our initial reporting in amino acid length (residues) is still
shown in columns two and four. It's how we document the particular instances where
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msTALI stands out to BsFinder; since they are comparable at first glance. However, all
of our results – msTALI for ASD – fit within reasonable bound of the confirmed sizes for
each protein (whether verified total length or confirmed active-site size).
Discussing precision and recall is straightforward once conserved residues are
reported and compared to the confirmed active-sites. Through comparison, we use the
conserved residues that are found and confirmed for evaluation. From Figure 4.5, the
seventh column first lists the precision value we mentioned, followed by a second
number, the calculated recall. We report our results alongside those of BsFinder [18],
highlighting our instances of outperformance. We've marked values yellow for precision
and cyan for recall when msTALI is superior. Values colored grey highlight msTALI
results less than that of BsFinder but by no more than five percent. The nuances that arise
from evaluating this particular target set of proteins are addressed directly [31]. Still, we
acknowledge the drawbacks witnessed with some exampled proteins or fold families
within the target set. It would appear that our method is relatively comparable; however,
our approach is ahead 73% of the time for this study.
Moreover, our results are consistent with a maintainable point of reference in
PDB. Overall, when comparing the initial accuracy of our method, we fair higher across
the board. This remains the case, even when a broader set of proteins is studied. Our
averaged precision is 37%, and our recall is 84%, as reported in Table 4.7. All of the
aforementioned supports our approach lucrative for ASD.
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Figure 4.4 The Super Imposition of Protein Fold Families. A. Superimposed structures for Proteins 1A2B (green),
1CXZ (orange), 1DPF (grey), 1FTN (red), and 1SIC (blue) from the G proteins family in P-loop folds. B. Proteins
1D7E (green), 1F9I (orange), 1KOU (grey), 1NWZ (red), and 2PHY (blue) form the PYP-like family in Profilin-like
folds. C. Proteins 1B4V (green), 1B8S (orange), 1COY (grey), 1IJH (red), and 3COX (blue) from the FAD-linked
reductases family in FAD/NAD(P)-binding folds.
.
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Figure 4.5 The Confirmed Protein Information needed for Precision and Recall. Using PDB we’ve listed the length by
amino acid residue and the length in atoms. We then compare the precision and recall for msTALI and BsFinder. Results
from BsFinder were previously reported [16]. With *a. the first number is the number of output sites reported by the
program (conserved regions in our case), the second number is confirmed sites from the program. For *b. and *c. the first
number is the precision value (%), the second number is the recall value (%) for both msTALI and BsFinder approaches
respectively. Reporting by residues is consistent with documentation.

Table 4.7 Program Evaluation Comparison on Fold Families. This table includes a
comparison of four discussed programs as reported from a previous study observing 55
sets of proteins (our results for msTALI are set alongside)[18].
Program

Precision

Recall

msTALI

37%

84%

BsFinder

34%

82%

SiteEngine

21%

47%

SuMo

11%

25%

pdbFun

15%

11%

To complete our evaluation study, we illustrate the conserved core region by
simultaneously aligning all 15 proteins; we then provide an example from each fold
family. This establishes the foundation of our ASD and is pictured in Figure 4.6. Each
illustration serves as an abstraction of the overall ASD for the proteins highlighted.
Figure 4.6A illustrates the conserved region for protein 1A2B, Figure 4.6B does the same
but for protein 1D7E, and Figure 4.6C depicts protein 1B4V. Figure 4.6D is a
superimposed surface representation of the conserved core regions across A, B, and C
and exemplifies structural similarity. To highlight the similarities further, Figure 4.6E
renders the same motif for secondary structure. The depicted conserved core regions from
msTALI are consistent across all target proteins. Confirmed active-site regions are
surface accessible or at the center of cavity/ cleft locations respective to a protein family
and are located at the coil, non-structure, or turn and bend regions at the beginning of the
alpha-helical region of each target proteins conserved residues [34][35][36]. We observe
that our simultaneous alignment on all 15 proteins yields precise results, characterizes
motifs common to all the proteins observed, and endorses the validity in active-site
bindings unique to each protein.
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Figure 4.6 The Conserved Core Regions. Each example is observable from three proteins, one from each fold
family under the all-inclusive simultaneous alignment. A. The conserved core residues for protein 1A2B as
obtained from msTALI. B. Comparative results for protein 1D7E. C. Comparative results for protein 1B4V. D.
Illustrates the superimposed regions from A to C. E. Depicts the secondary structural area from D.

Our evaluation study established comparison characteristics for our overall
approach. We develop a plan for documenting active-sites by visualizing the top-ranking
protein from studied target sets. The framework is then applicable to future studies. The
simultaneous alignment relation to active-sites is convincing alone. However, the
inconsistencies across approaches make it difficult to characterize a holistic mechanism
for identification evaluation. We assert the continual use of PDB for validating
documented proteins. Again, we note that our method is competitive and applicable to
broader ASD studies for multiple enzymatic activities.
4.2.3 Focused Study of Proteins
Our underlying hypothesis states that when the structure-sequence alignment of
multiple proteins with common function is performed, we will reveal the conserved
regions, which must contain the active-site and motifs salient to functionality; this indeed
holds as our primary aim is to successfully qualify several regions directly related to our
claim for a selected group of enzymatic activities. Our methodology stands out since it
doesn't require the computational and often exhaustive exploration of substrate
conformations seen with docking techniques. Further, experimental descriptions are
expensive and time-consuming. We move to an ASD description that expands beyond
our preliminary studies.
Our protein classes include AMP, ATP, FAD, FMN, Glucose, Heme, Hydrolase,
NAD, Phosphate, and Steroid functioning proteins. Studies performed on these functional
classes have had success, stress the importance/ relevancy of each functional group, and
even test the variation in shape locals' binding [20]. We review each class of proteins in
this section for our primary findings; they also advance our web-app development
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methodology. However, considering the complexity of the problems faced with ASD, we
have two ways to assess our results in this section. First, we compare our results to other
methods. Second, we highlight components from each class of proteins.
4.2.3A Summary Comparison of ASD with msTALI to Accepted Approaches
Our initial approach to evaluation explored the precision and recall of our method.
Remember that precision virtually reports the percentage of results that are indeed
lucrative. The recall is the number of active-sites that are recoverable provided we assess
errors. In each metric, we are testing our approach for accuracy based on available
documentation. Accepted practices have fared, having precision below thirty-five percent
and recall values roughly eighty percent [18].
Further, some instances have acceptably exercised accuracies as low as eleven
percent. We detailed the specifics of observed methods in Table 4.7. To this point, our
primary results are aggregated together in Table 4.8, where we report each class of
proteins precision and recall using our method. Notably, our precision values are all
upward of thirty-five percent. When compared, our recall values outweigh established
approaches threefold, even in worst-case examples. From Table 4.8, our first column
highlights the confirmed function for each study's set of proteins. We've included our
summarized results from preliminary evaluation studies detailed in section 4.2.2. We
examined upward of ten classes of proteins for validation. We summarize our results in
the last row of the table. We express the total precision and recall as an average across
sets. Despite our findings exceeding standards, there is still room for improvement.
However, many emerging ideologies that expand understanding are reaching ceilings in
advancement. Consequently, the current focus in active-site discoveries is equally vested
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in standardizing the evaluation of approaches [29]. To this point, we resort to
representing results for our protein studies visually.
Table 4.8 The Primary Precision and Recall for Our Approach. Each class of studied
proteins is reported and averaged for a total representation of performance on ASD.
CLASS
AMP
ATP
FAD
FMN
GLC
HEM
Hydrolase
NAD
PO4
Steroid
G(3 folds)
Across All Activities

PRECISION
36.2
57.0
37.3
70.7
38.8
48.5
36.5
56.5
48.2
39.9
37.0
46.0

RECALL
93.5
94.6
96.4
95.7
86.6
95.8
95.8
90.6
94.0
69.3
84.0
90.1

4.2.3B Composite Results Highlighted Based on Enzymatic Activity
Evaluation of computational methods aiming to identify active-sites is disjoint.
The lack of standards stems from ranging approaches, intricacies of the problem in
general, and the direct means for comparing results. We have reported our results for
ASD with an average precision of 46.0% and recall of 90.1%. Still, several of our studied
proteins do not have a standard for evaluation or another computational approach for
comparison. Further, if a method is available, it is not sure to adhere to annotations from
the PDB or any other formal repositories. This section includes additional context for
processing our precision and recall. It is notably beneficial to relate to how our results
engage implementation since we have reported how our approach fares better for our
studies. More so, this section highlights our studies' results based on visually showing
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regions we assert are exemplary to the ASD for the target classes of proteins. We
visualize motifs as a collective and highlight individual protein from our focused studies.
From our summary, we establish that our average precision is 46.0% and recall is
90.1%. Additionally, even with values higher than those having established use, visually
rendering results serve most beneficial for well-rounded representation. Still, we must
provide details that aid in interpreting the success of our method. We include the receiver
operating characteristic (ROC) curve [37] for our approach and other details for more
context. For the focused study, 4,380 protein residues were significantly recognized, and
2,125 of these residues were confirmed active-sites. This ratio is just upward of our
reported average precision. We also stress that several of the false positives are beneficial
to annotation and provide insight to function. The full acknowledgment for significant
confirmed residues is noteworthy. With our ASD, we suggest recommendations that
serve single protein evaluation differently. For example, we report a precision of 46%,
but, again, our collective success ratio from above is nearly 50%. Understand that an
individual protein has a different ASD than others in its class but often share several
signatures. Essentially, our observations are balanced by class and unbalanced when
considering the proteins that make them.
On average, for a span of 332 observations, we obtain an F-measure of 0.53 from
precision and recall. Our F-measure is lucrative provided the problem. Moreover, when
transitioning to contextual evaluations for proteins from a class, roughly 230 of the
observations are classified as confirmed active-sites. Figure 4.7 shows the ROC curve for
our method of ASD, based on the reported residues from our focused study. Graphed in
the figure, we map our sensitivity and the complement of our specificity.
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Figure 4.7 Active-Site Identification ROC curve. The graphed ROC curve for our method of
ASD provides details related to the number of active-sites found for proteins within a study.
This analysis further alludes to the number of times proteins should undergo alignment for ASD
before compromising our reporting. Our Green marked data point is our recommended standard,
and the yellow point is within a manageable range.

Together, the two graphed metrics convey the tradeoff between false-positive and truepositive rates. We have highlighted two data points, one green, and one yellow, and use
them to directly explain what comes from Figure 4.7. Our green point has a sensitivity of
0.41 and a false-positive rate of 0.20. The yellow data point has a sensitivity of 0.54 and a
false-positive rate of 0.35.
We highlight these regions because they most support our methodology. The
highlighted regions from our ROC curve coincide with the observable conserved regions
that result from a msTALI alignment. Our green point informs us that when twelve
conserved residues are returned, we will most likely have a successful ASD for a studied
protein. Our yellow point represents ten conserved residues (we point this out since the
grouping does not diminish results too much). Analysis with the ROC curve affects our
approach by establishing the standard for simultaneous and subset alignments. Directly,
our recommendation is four sets of alignments. Our green point supports this with a
general acceptance at 12 conserved residues. We observed complete correctness for the
classification of these observations as active-sites/ functionally significant were all
present.
Further, with 12 residues run four times, based on alignment, we maintain our
Threshold. The overall Threshold is 55 residues, and with 48 residues, we do not exceed
it. Anecdotally, we could use values below the recommended cutoff (green point), but
those instances are best suited for exceptional cases where the targeted class of proteins is
well defined. The use of precision, recall, the ROC curve, and evaluation in general all
provide contributory insight for our approach. However, we still stress rendering proteins
to provide first-hand examples for the conserved regions we associate with ASD.
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Our focused study examines ten classes of proteins. A protein from each class is
selected to expand our report. We also detail findings for our top ranking functional class
(FMN functioning). All depicted proteins rank amongst the top three results from their
respective studies. This reporting strategy calls attention to findings while stimulating
observations made through validation from the PDB annotations. We first describe the
recovered ASD for FMN. We then list the collective regions in Table 4.9, along with the
sequence information. Notably, we list the amino acid sequence only for our prevalent
findings in all the functional group proteins. To conclude our focused report, we picture
the corresponding visual representation for each protein.
FMN functioning proteins rank highest amongst the ten function classes. Several
responses suitably describe why one studied class evaluates higher than another.
However, the intermingling details become overbearing for our primary aim; as expected,
there are anomalies within each set, which do not impact the larger theme and fall outside
the scope of our focus. FMN (Flavin mononucleotide), as many targeted functional
classes, is very prevalent in biological interaction. Specifically, FMN has involvement
with metabolism, and its believed interactions play a role in the electron–transfer
pathway [38]. We notice that protein 1FLM from our FMN study was evaluated
exceptionally well. Reasons attributing to 1FLM being standout are primarily its size and
relationships. 1FLM is the smallest of FMN binding proteins; it is 122 residues in length
and further binds only with FMN. Figure 4.8 highlights the ASD we characterize with our
approach. The regions highlighted red are confirmed active-site residues that are contact
regions. The blue is our found overlapping regions, which consistently fit –
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Figure 4.8 Highlighting the ASD for Protein 1FLM. We use red to outline confirmed
active-sites residues from PDB. Blue are overlapping regions consistent with our
findings. Yellow regions are prevalent in all proteins from the corresponding functional
class.

with the confirmed active-site. The yellow corresponds to residues within the protein
1FLM that are also structurally present in all the studied FMN proteins.
With 1FLM, we have afforded a complete protein level description for our
focused study of proteins. Further, our ASD includes both active-site and functionally
significant residues. Overlapping regions directly facilitate function. Most notably, by
serving as the structural clamp-like feature that fosters the hold at the docking location.
These physical interactions are supported by the hydrophobic and hydrophilic
interactions at the site, as well [38]. Again, we expand these results to the FMN class, use
the same convention across all classes, and expound on how they link to composite
results.
Results illustrated in Table 4.10 directly map regions consistent with reported
residues in PDB. In other words, each structural representation – colored blue – is an
overlapping region constant to our approach. Yellow areas are highly conserved residues
indicative of all the proteins studied from their respective class. It is salient to mention
the colored areas for two reasons. First, the overlapping residues, assure that our
identified regions are functionally significant. Second, yellow regions are holistic and
stress the studied class's relationship and any homologous protein moving forward.
Both points are unique to our approach and have impactful implications. For each
component of our focused study, we have found structures critical to function. We see
that regions are sometimes just as well-formed as they are dynamic. By, connecting
proteins based on their functional relationships, we can rapidly approach current issues.
This serves as beneficial for the annotation and drug design of any protein of interest for
real-world applications.
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Table 4.9 Annotation for Focused Study Proteins. From our focused study, we outline the ten top-ranking proteins for each group. The
confirmed conserved residues are confirmed as causal to function from PDB annotation. They are also based on proximal relevance.
Standard functional listings report residues that are present in all studied proteins for the respective class. We list the sequence
information for these regions. Highlighted residues are colored blue and yellow, respectively, and visible in Table 4.10.
Protein

Confirmed Conserved Residues for ASD (blue)

1CT9

1, 2, 3, 4, 5, 6, 7, 40, 41, 42, 43, 44, 45, 46, 47, 48,
49, 50, 51, 52, 70, 71, 72, 73, 74, 75, 148, 149,
18, 19, 20, 21, 22, 23, 24, 45, 67, 75, 76, 77, 78 79
102, 103, 104, 105, 107, 108, 154
8, 9, 10, 12, 13, 20, 21, 22, 23, 24, 25, 45, 46, 47,
48, 49, 50, 51, 54, 55, 58, 61, 62, 67, 78, 79, 80,
81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 100,
12, 13, 14, 15, 16, 17, 18, 19, 51, 52, 53, 54, 55,
56, 57, 58, 59,
14, 18, 20, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39,
40, 41, 42, 43, 149, 150
34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46,
47, 48, 49, 50, 51, 278, 279, 283, 287, 288, 289
9, 18, 19, 20, 21, 22, 25, 26, 27, 28

1E2Q
1JR8-B
1FLM
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4R2B
1QPA-B
1V2G
1OG3
1DAK
1E3R-B

5, 66, 67, 81, 83, 84, 92, 93, 94, 95, 125, 126, 127,
128, 129, 130, 131, 132, 133, 144, 189, 193, 195
10, 11, 12, 13, 14, 15, 16, 17, 32, 33, 34, 35, 36,
37, 50, 51, 78, 79, 80, 81, 83, 152, 153, 154,209
13, 14, 16, 17, 18, 19, 20, 21, 22, 98, 99, 100, 101,
105, 111, 119, 120

Common Functional
(yellow)
1, 39, 40, 41, 42, 43, 44, 45,
46
17, 18, 19, 20, 22, 23, 24,
25
45, 46, 47, 48, 49, 50, 51,
54, 55, 58

Common Functional
Sequence
AASDNAILA
VDRAKSTQ
YAELYPCCSF

12, 13, 14, 15, 16, 17, 18,
19
30, 31, 32, 33, 34, 35, 36,
37
38, 39, 40, 44, 46

NEGVVAIA

18, 19, 20, 21, 22, 25, 26,
27, 28
27, 31, 32, 37, 38, 39

SASAAALLN

32, 33, 34, 35, 36, 37
11, 12, 13, 16, 17, 18, 19,
20, 21, 22, 70, 105, 111,
112

LEKKGISW
EAHRV

ELFNM
RTAGYK
GLMARYIELVD
VLMGR

Table 4.10 The Prominent Protein Features for the ASD on Focused Studies. Images A. through J. depict conserved residues obtained
from our approach that is also confirmed binding regions in PDB (blue). We find that Yellow regions are in each protein within a set.
B. 1E2Q

C. 1JR8-B

D. 1FLM

E. 4R2B

AMP

ATP

FAD

FMN

GLC

F. 1QPA-B

G. 1V2G

H. 1OG3

I. 1DAK

J. 1E3R-B

NAD

PO4

Ster.

77

A. 1CT9

Heme
e

Hydr.

4.2.4 Current Applications of ASD Through msTALI
The utility of msTALI for active-site identification and, more specifically, the
ASD of proteins are primarily based on researched studies. The studies, as mentioned,
typically have some known components based on documentation. All of which is useful
for testing and verifying our aim. Evaluation is essential, and our accuracy ensures that
our method is sustainable. Nonetheless, the invaluable task is applying our newly
developed method on novel protein structures, current matters worth analysis, and any
combination of those fitting to the times. Within this section, we outline two applications
of ASD. The first takes advantage of several techniques observing a novel protein
structure, and we focus on the contributions of msTALI. The second application is related
to the pressing issues relating to COVID-19. In both cases, annotation is critical, and we
use these examples to strengthen our methodology's reach to real-world practice. The
importance of protein functional discussions is relevant. From annotation to drug design,
computational methods are directly beneficial to expanding the field's common core
principles.
4.2.4A Nonstructural Protein Annotation for NSP1 in SARS-CoV
Real-world application for our approach is inescapable. We have verified our
results through comparison studies and move forward with advancements observing less
annotated structures. Our first example here is conducted on nonstructural protein 1
(NSP1). We observe NSP1 due to its cleaving characteristics from SARS-CoV studies.
NSP1 is of the nsp family of proteins and the first to be translated [39]. It causes severe
translational shutdown of host proteins from host mRNAs and, in turn, suppresses host
gene expression. Additionally, its structural makeup has three regions, two unstructured –
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domains, and the other is structurally well-defined. Further description lends to
cataloging the 180 residue makeup. Residues 1 – 12 and 127 – 180 are unstructured, and
13 – 126 are structurally well-defined [30]. Provided that genomic information is
available, we still need to explore the functional qualities. Consequently, we rally our
ASD approach for novel developments with supporting computational approaches
investigating regions of interest for NSP1 [30].
ASD for NSP1 is a lucrative pursuit since the structure-function relationship has
direct implications for COVID-19. Other studies for COVID-19 focused on spike
proteins binding to the lung cell receptor ACE-2 [40]. Here, our relationship of NSP1
with SARS-CoV widens our understanding of SARS-CoV-2 (COVID-19) based on
homology. We use our methodology to study NSP1's disordered regions in a manner that
proves challenging for traditional methods. We apply our method and integrate it with
other computational approaches and experimental validation for a well-rounded
collaborative markup for function. Through laboratory-based experiments, two regions of
NSP1 were explored and shown to alter its ability to shut down host gene expression
[30]. We believe that these mutations' implications are structure-functionally significant
for the protein and expandable; we show the potential regions in Table 4.11. For a
complete consideration of NSP1's function, we corroborated our findings for ASD with
the structural modeling of I-TASSER [41] and deep mining of the PDB using PDBMine
[42]; collectively, this affords a reliable deciphering of NSP1 in a timely manner that
escapes traditional applications.

79

Table 4.11 Gene Expression Inhibiting Residues of Interest. Laboratory confirmed
mutations that inhibit host gene expression by amplifying NSP1’s function.
Gene Expression Inhibited by 150-450%
E55R, E57R, K58E, G59R
R73E, D75R, L77A, S78E, N80G

Again, we focus on our direct ASD results as active-site studies are also essential
for expressing proteins' functional operation. Our contribution upholds the methodical
convention described throughout section 4.1. These controls include the number of
targets and diversity in structure while maintaining functional relevance and binding to
NSP1. Table 4.12 highlights our preliminary target set for alignment. We list their length
in residues and C.A.T.H. classification (if available) to ensure our approach is selfcontained. Our standards are maintained, and our criterion is mobilized for ASD.
Table 4.12 Preliminary Protein List Related to NSP1 Functional Activity. Here we
supply the list of proteins with related functional activity to NSP. They were used with
msTALI for ASD.
PDB-ID
1HUS
1IQV
1VI6
1QKH
1QXF
1RIP
1RSS
2FKX
2MEW
3BN0

Size
155
218
208
92
66
81
151
88
82
112

4BSZ

244

6G04
NSP1

156
180

80

CATH
1.10.455.10
1.10.455.10
3.40.50.10490
3.30.860.10
2.20.25.100
2.40.50.140
1.10.455.10
1.10.287.10
3.30.70.600
3.30.1320.10
3.30.300.20| 1.25.40.20|
3.30.1140.32
NA
NA

With the following, we address the resulting annotations obtained from using our
msTALI based method for ASD. The results of the alignment of the proteins listed in
Table 4.12 are shown in Figure 4.9. In this figure, each region of the protein is marked by
its residue number. Higher scores correspond to regions of the protein that are conserved
and deemed significant for our typical ASD. We list peaks in Table 4.13, where each
conserved region is named by the residues it spans, and described the degree of surface
accessibility. There are two particularly interesting observations. The first indicates the
importance of region 73 – 80, one of the implicated functional regions of NSP1. The
second observation relates to the near-complete absence of any reported significance for
the region 55 – 59. This is highly related to the structural similarities amongst the target
set for ASD. The accompanying proteins have relevant binding properties. Consequently,
region 73 – 80 is more likely the initial binding site to the rRNA complex. Further, it can
be hypothesized that the additional regions (1, 2, and 4 - Table 4.13) are requisite
supporting regions that facilitate the docking process at residues 74 – 83.
Table 4.13 Surface Accessibility for Conserved Regions of NSP1. The conserved regions
across the alignment of NSP1 with the remaining twelve proteins of the target set. All
proteins have functions related to that of NSP1.
Name
Region 1
Region 2
Region 3
Region 4

Range
7-15
22-29
74-83
139-146

Surface Accessibility
Partial surface exposure
Partial surface exposure
Complete surface exposure
Minimal surface exposure

Our method's significant regions coincide with both the focused regions and
additional residues that we reliably advocate as functional facilitators. The consistent
backings for residues 73 – 83 are promising, and the others are beneficial to our overall
ASD based on structural similarities. We summarize the results by rendering the protein –

81

structure for Wild-type NSP1 in Figure 4.10. The established regions outlined in Table
4.13 and Figure 4.9 are colored green. The mutation/ focused regions outlined in Table
4.11 are colored red. We then highlight the overlap of green and red regions, blue.
Residues highlighted blue (73 – 83) consistently stand and are critical binding sites in the
ribosomal binding function. We reiterate our results exclude the region 55-60; however,
with additional observation, a region emerges with supplementary potential. The yellow
region in Figure 4.10 is added to our markup for this reason. We discuss its proximal
significance further in section 4.2.4B. Collectively, the rendering of NSP1 is the
culmination of our observations. Proximal locations join our computational descriptions
[30] for a reliable annotation. We see that despite divergent mechanisms for function, our
ASD includes functionally supportive regions for biochemical interaction. Findings are
all well suited as a foundation for COVID-19 studies based on homology [39].
4.2.4B Application of The msTALI ASD for COVID-19
Transitioning from important novel structures, we engage in establishing
templating approaches for a known protein, based on its relational lineage and despite its
unclear description for its active-site relationship. We focus on structure 6LU7 for our
COVID-19 study, and we link its importance to previous viral outbreaks. We link its
impact to severe acute respiratory syndrome (SARS). The SARS virus sparked interest in
the early 2000s as its outbreak reached the masses. To date, the coronavirus named
COVID-19 has directly affected the mode of living and interactions at a global capacity
and for the overwhelming majority. The current understanding of the coronavirus's
lineage suggests viral flexibility that is also problematic for the future.
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Figure 4.9 The msTALI conservation score for SARS-CoV-1 NSP1 protein as reported with the other proteins from the target set. A
higher score is an indication of a more significant conserved region.
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Figure 4.10 The Visual Rendering of Wild-type NSP1. We represent and highlight observable regions for SARS-CoV-1 NSP1 resulting
from our ASD. Highlighted protein residues correspond with our highest conserved core results, experimental focused regions for
mutation, templated results, and the common residues between the conserved core and experimental regions. We color each region
green, red, yellow, and blue, respectively.

With such, the viral genome is readily studied and of interest. Further, even knowing that
the SARS and the coronavirus COVID-19 are RNA inhibiting, the specific gene products
are still relatively unknown, especially when describing function [43].
We apply our method of ASD to COVID-19 with an additional observation of the
following proteins: 1DIV, 1DK1, 2C3S, 2GHV, 3QOY, 5CWS, 5GQT, 5WRG, 6ACD,
6LU7, 6W02, 6Y2G, 6Y84, 7BTF, and NSP1. The selected list is built from continuing
our protein structure-to-function study on NSP1. Since there are details elusive to our
documentation of 6LU7 – our COVID-19 structure – we use additional available
resources. We incorporate our leading ASD description from simultaneous alignment
with our novel results and reference materials obtained from PDBsum [44] to build our
story for 6LU7. More specifically, we highlight relationships between the simultaneous
alignments of protein 7BTF and the NSP1, as mentioned earlier.
We observe seven residues across the proteins that are highly conserved. These
seven residues then become the basis for motif characteristics for each protein in the ASD
study. From Figure 4.11, the seven residues are plotted by residue location for each
protein. The peaks correspond to the conserved regions, and we see there is also proximal
similarity across the set. We highlight additional proteins of interest concerning 6LU7.
Graphs J, N, and O from Figure 4.11 are noteworthy because their proximal
similarity is also linked to documented regions of importance. With protein 7BTF ("N"),
all seven residues are confirmed active-sites, making it the best fit result for the initial
motif definition. The confirmation of residues alludes to the region's propensity to fit
directly for the overall target set for ASD and make it a reliable template for our focused
6LU7 graphed in J.
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For NSP1 in O, we again observe conserved regions noted to facilitate its
function's initial steps. In these studies, regions once missed are more prominent [30].
Notably, the emergence of the supporting area is not direct. However, this is not
surprising as the presence of different host factors – RNA or Protein – affect the
supporting residues aiding the function for ASD. Particularly, we discuss the residues 50
– 54 highlighted yellow in Figure 4.10. Several established methods for active-site
identification group neighboring regions with the site. Base on proximity, the same is
acceptable for our mutation region at residues 55 – 59 [30] for NSP1. All residues are
within five amino acid locations of each other (spanning ten residues in total). Thus,
labeling the emergent region as functionally supportive is lucrative. Region 50 -54 is also
a beta-structured region connected to the nanostructured residues 55 – 59; we valuably
add them to the markup for ASD. Our observations now include several conserved
features that are adequately applicable to 6LU7.
4.2.4Bi Identifying Prominent Features in COVID-19 for ASD
There are well-documented structures, novel structures, and several that are
annotated far less despite being known and classified among our target proteins. We
reiterate this because it is causal to the templating concepts for our method verification.
COVID-19 is one of the less annotated proteins for function. However, we have an
understanding of its impact. Expressly, 6LU7 [45] – our studied COVID-19 structure – is
confirmed in PDB as having an active-site consisting of only two residues; this is small,
and roughly twenty percent of that size confirmed for 7BTF (our template/ reference for
ASD). Other mentioned residues for 6LU7 are referenced from PDBsum. These
annotations are ambiguous.
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Figure 4.11 The msTALI Conservation Score for Templated Set. Proteins are alphabetically listed
A through O for proteins. Higher scores represent significantly conserved regions for each protein
based on residue location. Proteins of focus are highlighted green.

They are not labeled as active-site or functionally causal. Instead, they are said to come in
contact with ligands [44]. We initiate our analysis of 6LU7 using the complete
conservation score to disambiguate annotation. The complete score plots for ASD is in
Figure 4.12. The msTALI conservation score exhibits four primary peaks consistent with
our findings.
4.2.4Bii Critical Protein Residue Rendering for COVID-19
To visualize our charted conserved regions, we list the protein residues first. The
framework affords a relationship for regions we visualize for evaluation. We consider
both the confirmed active-site and documented highlighted residues to evaluate our
approach since the PDB confirmation is small. From Table 4.14, column two lists the
residues we obtain with our approach, column three confirms PDB annotation, and the
fourth outlines highlighted regions from PDBsum. Using our technique, we recognize
forty-nine residues. There are two from PDB [24] and twenty-one from PDBsum [44].
The reported comparison regions share thirty-two residues in common based on residue
number, threshold, and proximity [31]. We visualize these details to highlight their
potential causality to function. The visual representations are increasing interesting for
two reasons:
1. We can verify spatial locations for residues and identify residues for the overall
protein. These qualities can allude to the alleged role of residues. Which, in turn,
highlight functional classifications and provides well-formed ASD.
2. With the protein models, similarities between 6LU7 can 7BTF are more noteworthy.
The templating approach is supported and reinforces the range in methodology. We
directly assert that our ASD results are replicable for other functional interests.
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Figure 4.12 The msTALI conservation score for protein 6LU7. Higher scores represent significantly conserved regions for each
protein based on residue location. The x-axis charts the amino acid residue numbers for said protein; corresponding scores are
plotted along the y-axis.

We address the first interest for visualization next, as it pertains directly to the
ASD for 6LU7. Our second interest is described in our next section since it relates to our
methodology and how similar strategies from our method apply for the community
response.
Table 4.14 Reporting Conserved Regions for Protein 6LU7. The residues obtained from
the msTALI ASD are reported first, followed by the PDB confirmed active-site, and then
notable regions are added from PDBsum reports.
Reported Protein Residue Numbers
Named Protein

6LU7

msTALI
ASD
9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19,
20, 21, 22, 23, 24,
25, 29, 30, 31, 32,
33, 96, 97, 98, 99,
100, 101, 102, 103,
104, 128, 132, 151,
152, 153, 158, 169,
171, 180, 184, 185,
186, 187, 188, 189,
190, 241, and 247

PDB Active-Site
Conformation
41, and 145

PDBsum
Highlighted Regions
24, 25, 26, 41, 140,
141, 142, 143, 144,
145, 163 164, 165,
166, 168, 172 188,
189, 190, 191, and
192

Related to our first interest, Figure 4.13A and Figure 4.13C provide
corresponding representations for 6LU7. Figure 4.13B and Figure 4.13D are
corresponding representations for each other as well. In each case, we display the
secondary structural representation followed by a protein surface representation. Protein
residues highlighted green represent column two in Table 4.14, and residues highlighted
red and orange are columns three and four, respectively. Blue residues highlight
overlapping residues consistent with our findings and the documented/ referenced areas.
From a proximity/ spatial perspective, all highlighted regions surround the large
centralized cleft of the protein. The individual representations provide descriptive
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observations. In comparing our results from Figure 4.13A with Figure 4.13B, our results
envelop the confirmed active-site. Figure 4.13B region highlighted orange, covers the
face of the cleft. Pictured in Figure 4.13C and Figure 4.13D, the confirmed as active-site
(red-marked) are primarily submerged within the cleft. The contact ligand representation
(orange) covers the cleft surface/ geographical area in Figure 4.13D, while our found
ASD locations (blue) highlight the borders/edges of the cleft. These details are essential
for motif characterization and further support surface accessible regions' functional
responsibility.
We maintain that having two residues declared for an active-site is limiting.
However, we also have the orange highlighted region from Figure 4.13B, which are far
more similar to our results. Using a templating approach with protein confirmed similar,
we can assert our ASD result as regions that aid function. Our ASD for 6LU7 conveys
more than highlighted structures that cup the cleft. The proximal significance has
resounding implications for the ASD. As we look further into the motif itself, structural
components display convincing evidence that residues' role facilitates the function; they
line the cleft, engulf the active-site, and are in surface accessible regions that can close
off access to the cleft as a whole.
4.2.4Biii ASD Motif Rendering for COVID-19
The proximal similarities are significant, and the functional implications are
intriguing. Closeness to the active-sites or any other protein residues deemed interesting
is directly observable and pragmatic. However, the relationships from our studied protein
set are less intuitive. The template reference is used as a framework establishing an ASD
signature for studied classes of proteins. To visualize these points, we focus now only on
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the characteristics templated from 7BTF to 6LU7. In doing so, we show the noteworthy
features for the viral proteins of our target set. The visual representation of our ASD
moves forward our second interest. We evaluate our approach's effectiveness for 6LU7
and demonstrate our application as suitable for reshaping the means for addressing other
functional activity, whether for ASD annotation or insight.
In Figure 4.14, our rendering of the ASD for 6LU7 focuses on our motif's
structural aspects. We establish their similarities with our template structure and observe
significant and exhibited regions across all of the target proteins. First, we highlight the
primary residues from 6LU7 and 7BTF obtained from all targets' simultaneous
alignment. Residues 184 – 190 are colored purple for 6LU7 and directly correspond with
magenta-colored residues, 642 – 648 of protein 7BTF. This region is highly conserved.
This region is prevalent in all of our observed proteins; it describes the peaks from Figure
4.12. Additionally, the residues highlighted for 7BTF are confirmed active-site. We
establish the conservation and superimpose these regions in Figure 4.14, noting that their
non-secondary structure conforms, and is fitting to active-site descriptors.
From the comparison of our base region, other template fitting features become
prominent. We establish what is comparable and useful for both the ASD of 6LU7 and
any related functional examples. Protein 6LU7 is colored green, and 7BTF is colored
cyan. We discern two additional pairing regions that match the purple and magenta
described regions in Figure 4.14. The similarities are strikingly similar for the two
accompanying secondary-structure heavy areas to the upper-left and lower-right. The
other paired region has little secondary structure conformity and is similarly positioned at
the top of the figure above the initial highlighted region.
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With Figure 4.15, we hit home the point of our templating and motif. The
remaining regions without secondary structure are visually paired features. Consequently,
Figure 4.15 focuses on the first-mentioned (structured) paring region. Observations are
pictured consistent with the setup for Figure 4.14. We observe a helical region connected
to a beta-sheet by a coiled region; they are prominent templating features. Another helix
for both 6LU7 and 7BTF is pictured top center. These regions are similar and occupy
different areas within the figure (a shift instead of a direct overlap) based on the overall
focused superimposition.
Overall, the ASD of 6LU7 is consistent with referenced protein residues. This
makes up for the confirmed active-site residues being less prominent. We establish
similarities from 6LU7 templated from 7BTF. We have also outlined how our results are
crucial for proximal, functional, and structural protein discussions. Additionally, the
location and structures found within our motifs support classifications of many
COVID/CoV-2 structures referenced as hydrolases [46]. These findings show promise.
We produced an average precision and recall of 61.91 and 96.63 percent for 6LU7.
The practical implications of these results lend to descriptions for functional
shutoff. Our results are most plausible because our results give way to dynamic and
functional regions that facilitate binding and active-site exposure mechanisms. Targeting
the responsible residues is possible, limiting the dynamics and impeding active-site
exposure—for example, lid obstruction employed for SARS-CoV-2 proteins described as
hydrolases. Collectively, ASD is distinctly useful, and our primary aim is addressed.
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94
Figure 4.13 The Picture Representation of Protein 6LU7. A. In red, we highlight the
confirmed/ known active-site. Green highlights residues found with our approach. Blue
are overlapping regions for our findings and any confirmed or referenced residues. B.
Orange colored regions are confirmed residue locations for contact ligand. C and D are
the equivalently marked surface representation for 6LU7. We use all depictions in the
discussion of the ASD for 6LU7.
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Figure 4.14 Templating the ASD for Protein 6LU7 with 7BTF. We superimpose residues
(pictured purple (6LU7), pictured magenta (7BTF)), leading to the emergence of three motif
pair characteristics conserved across the signature of SARS-CoV-2 / viral proteins alike. The
green protein is the ASD we find for 6LU7, and protein 7BTF is colored cyan.
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Figure 4.15 Templating the ASD for Protein 6LU7 with 7BTF. Orientation based
on main secondary structures of the motifs conserved across the signature of
SARS-CoV-2 / viral proteins alike. The green-colored protein is 6LU7, and
pictured in cyan is 7BTF.

CHAPTER 5
DISCUSSION
The msTALI tool is expandable to applications for active-site identification. We
have developed a methodology highly implementable for what we have categorized as
the ASD for a protein. Further, this ties to the collective ASD for groups of proteins
exhibiting the same function. The distinguishable difference here is that our ASD
includes protein residues that are both exemplary of active-sites and supporting residues
for aiding said function. This also includes structural mechanisms conducive to activesite exposure. Multiple proteins support these descriptions simultaneously and, with such,
incorporation of homologous characteristics become applicable to various enzymatic
activity. The classification of targeted proteins secures that conserved residues are
relevant. We also applied PDB, CATH, and other available resources to uphold findings.
Again, our methodical development is predicated on the underlying hypothesis
that the structure-sequence alignment of multiple proteins with a common function will
reveal the conserved regions (structural and sequence) containing the active-site and
motifs salient functionality. Our approach is applied to over ten classes of enzymatic
activity to support our primary aim. The successful use of msTALI focused on AMP,
ATP, FAD, FMN, Glucose, Heme, Hydrolase, NAD, Phosphate, and Steroid functioning
proteins. Evaluation of our methodology reports an average precision of 46.0% and recall
of 90.1%. Though improvements are desired, we fare upwards of 10% in comparison to
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accepted methods. Additionally, to thwart the inconsistency faced for computational
evaluations, we have visually reported our findings too. Notably, our methodical
development's success lends to our subsequent aim to expand our tool and apply our
methodology to the current applications.
Beyond our focused study, we have employed our approach in observance of
COVID-19 studies. Here, the recourse leveraged homologous information from SARSCoV studies to the current SARS-CoV-2 studies and exemplified a templating approach
specifically for the ASD of COVID-19. Using structure 6LU7, we obtain an ASD with an
evaluation score of 61.91 and 96.63 percent for precision and recall. We used a
combination of the same functioning proteins with available documentation to verify our
findings. Mainly protein 7BTF was used as a primary reference structure along with
protein NSP1. We used both PDB and PDBsum for confirmed annotation. Our finding
and motif characteristics lend to regions that regulate the active-site exposure for 6LU7.
Here the practical use yields a functional shutoff framework to address COVID-19. We
mention a lid obstruction example since several SARS-CoV-2 proteins are also
categorized as hydrolases. Most notable, all the results we find are cost-effective. Our
approach requires far fewer resources than conventional research aiming to address
COVID-19 annotation, curing, and monitoring.
We assert that our methodology is suitable for a multitude of functional
descriptions. Our study on 6LU7 is the latest. Future works can always expand the
functional class annotation. However, two riveting advancements and applications to our
method are function prediction or multi-functional ASD. Function prediction is valuable
for drug-design, and, commonly, an individual protein has several roles. It would be
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interesting to explore how these concepts impact ASD. They are beneficial for common
core understanding and advancement in our development.
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